{"meta":{"query_hash":"a3c27dcb627f","filters":{"venue":"Cancer Treatment and Research Communications"},"cohort_total":49,"direct_labels_cover":0,"predictions_cover":49,"exported":49,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/a3c27dcb627f","api":"https://metacan.xera.ac/api/v1/cohort?venue=Cancer+Treatment+and+Research+Communications"},"results":[{"id":"W2543318099","doi":"10.1016/j.ctarc.2016.10.001","title":"The role of education in colorectal cancer screening participation: Updated evidence from Canadian Community Health Survey (2011–2012)","year":2016,"lang":"en","type":"article","venue":"Cancer Treatment and Research Communications","topic":"Colorectal Cancer Screening and Detection","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"BC Cancer Agency; University of British Columbia","funders":"","keywords":"Sigmoidoscopy; Medicine; Graduation (instrument); Colorectal cancer; Fecal occult blood; Psychological intervention; Context (archaeology); Colonoscopy; Logistic regression; Odds; Odds ratio; Family medicine; Demography; Cancer; Gerontology; Internal medicine; Nursing","score_opus":0.1935098833369035,"score_gpt":0.47111156786995706,"score_spread":0.27760168453305356,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2543318099","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.59326535,0.2941358,0.0009376758,0.025011022,0.0017257307,0.00055374525,0.05579545,0.00008712737,0.028488051],"genre_scores_gemma":[0.9378906,0.04894505,0.00095061306,0.003248284,0.0002885987,0.00013737497,0.006716427,0.00001804256,0.0018050325],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99507326,0.00094773533,0.00054202584,0.00049806753,0.0017465,0.0011924405],"domain_scores_gemma":[0.97845364,0.0058130785,0.0041231667,0.00067239685,0.007947298,0.0029903948],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0065092472,0.0006270058,0.00096729054,0.0025579068,0.0011923466,0.0019545383,0.0026752774,0.0017551633,0.003461354],"category_scores_gemma":[0.03250905,0.0006722631,0.0029291653,0.005701137,0.0009253254,0.0013283645,0.0016059331,0.002112594,0.0002045547],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008065963,0.00023926138,0.9069967,0.0046406076,0.0023987999,0.00015237372,0.0008895767,0.00033537936,0.000056387413,0.0003676534,0.013338599,0.069778025],"study_design_scores_gemma":[0.0000914148,0.000058474452,0.9908563,0.0017872546,0.0018067544,0.000036896046,0.0005015948,0.00013163139,0.000034319182,0.00006391788,0.0046047023,0.000026801059],"about_ca_topic_score_codex":0.97478217,"about_ca_topic_score_gemma":0.98469967,"teacher_disagreement_score":0.025217831,"about_ca_system_score_codex":0.011453502,"about_ca_system_score_gemma":0.033767764,"threshold_uncertainty_score":0.08310133},"labels":[],"label_agreement":null},{"id":"W2594051854","doi":"10.1016/j.ctarc.2017.02.005","title":"Challenging the Paradigm: EGFR wild-type benefit from an EGFR inhibitor in NSCLC","year":2017,"lang":"en","type":"article","venue":"Cancer Treatment and Research Communications","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia Hospital; BC Research (Canada); BC Cancer Agency","funders":"Boehringer Ingelheim; AstraZeneca","keywords":"Afatinib; Erlotinib; Gefitinib; Epidermal growth factor receptor; Lung cancer; Medicine; Erlotinib Hydrochloride; Oncology; EGFR inhibitors; Tyrosine kinase; Internal medicine; Cancer research; Cancer; Receptor","score_opus":0.16822991829360176,"score_gpt":0.49793433245532476,"score_spread":0.329704414161723,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2594051854","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.026838878,0.08334104,0.0043803486,0.8657696,0.0052632177,0.000035162597,0.00046557852,0.00005262788,0.013853495],"genre_scores_gemma":[0.5681118,0.08627092,0.0060954164,0.28723967,0.047317058,0.00014461986,0.00038924522,0.00010986267,0.0043214546],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9966055,0.0021069422,0.0002630994,0.00033204973,0.00048536956,0.00020696572],"domain_scores_gemma":[0.9880597,0.009179677,0.00085265737,0.00033752536,0.0007074311,0.0008630086],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.010190755,0.00038108462,0.0015147128,0.00056462415,0.00069657515,0.0030277616,0.001102496,0.0031279398,0.0055666426],"category_scores_gemma":[0.019785898,0.00021871993,0.0011133978,0.00048143032,0.0024998446,0.0070118285,0.001568778,0.009335375,0.0009900465],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006998064,0.0006043493,0.00905289,0.0017707659,0.0008807674,0.00070437475,0.00035368162,0.0055549364,0.0040358095,0.21005878,0.13671151,0.623274],"study_design_scores_gemma":[0.0021730436,0.0032059655,0.013361548,0.002900791,0.0012850631,0.0014923478,0.0010403979,0.0071946704,0.0019631851,0.7641459,0.20107031,0.00016675156],"about_ca_topic_score_codex":0.0015561404,"about_ca_topic_score_gemma":0.004226152,"teacher_disagreement_score":0.010190755,"about_ca_system_score_codex":0.00251577,"about_ca_system_score_gemma":0.00392907,"threshold_uncertainty_score":0.05389452},"labels":[],"label_agreement":null},{"id":"W2620604883","doi":"10.1016/j.ctarc.2017.06.002","title":"The influence of season and distance to a cancer centre on lung cancer treatment rates","year":2017,"lang":"en","type":"article","venue":"Cancer Treatment and Research Communications","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Lung cancer; Cancer; Medicine; Oncology; Internal medicine; Demography; Sociology","score_opus":0.08108672179372736,"score_gpt":0.5047361230608941,"score_spread":0.42364940126716677,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2620604883","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9930206,0.001271662,0.00030687577,0.0008677276,0.0001582888,0.000008352454,0.0012978989,0.000017356322,0.0030513443],"genre_scores_gemma":[0.99850804,0.00018755137,0.000054594144,0.00007064219,0.00006221257,0.000004026893,0.00032672405,0.000019212108,0.0007669567],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982175,0.0006308007,0.0001365784,0.00023870973,0.00013760287,0.0006387448],"domain_scores_gemma":[0.98322695,0.006702179,0.0039749015,0.00074822677,0.0008048089,0.004543012],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017811356,0.00019400458,0.00047674804,0.00062460895,0.0006171489,0.0016642244,0.0008360473,0.0007206162,0.007910453],"category_scores_gemma":[0.0102015445,0.0002637337,0.001367977,0.000993175,0.00046876044,0.00071887224,0.0009938722,0.0012100345,0.0006915676],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005834087,0.00007264575,0.99445385,0.000022716438,0.00023247658,0.000096995725,0.00015406337,0.0003417271,0.0002168963,0.000106579166,0.00048487,0.0032337275],"study_design_scores_gemma":[0.000006892898,0.00011515718,0.9980254,0.000014154454,0.00006954792,0.000078578014,0.00061101536,0.00039036668,0.0000675344,0.000058584603,0.0005559978,0.000006848858],"about_ca_topic_score_codex":0.03322825,"about_ca_topic_score_gemma":0.03746249,"teacher_disagreement_score":0.03322825,"about_ca_system_score_codex":0.00065354985,"about_ca_system_score_gemma":0.001654083,"threshold_uncertainty_score":0.06606966},"labels":[],"label_agreement":null},{"id":"W2790018618","doi":"10.1016/j.ctarc.2018.02.002","title":"Benefit of crizotinib in a lung cancer patient with discordant ALK testing results","year":2018,"lang":"en","type":"article","venue":"Cancer Treatment and Research Communications","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"CancerCare Manitoba; University of Manitoba","funders":"","keywords":"Crizotinib; Medicine; Lung cancer; Anaplastic lymphoma kinase; Oncology; Pleural effusion; Internal medicine; Radiology; Pathology; Malignant pleural effusion","score_opus":0.12461204940114946,"score_gpt":0.47865714152750405,"score_spread":0.3540450921263546,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2790018618","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.90917087,0.018551908,0.0011692038,0.035482224,0.0010459214,0.00012921526,0.001592799,0.00016244207,0.03269544],"genre_scores_gemma":[0.99075705,0.002361417,0.0006384649,0.0035999857,0.0006056569,0.000011658098,0.00067373324,0.00001566009,0.0013363884],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99976546,0.0000394988,0.000023442784,0.00004751129,0.00003915574,0.00008490474],"domain_scores_gemma":[0.99953973,0.0001405094,0.000055229462,0.000017936623,0.000030668143,0.0002158785],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025612314,0.00032268988,0.00080165075,0.00035183734,0.00064913626,0.00074485654,0.00037633337,0.0015532403,0.0029639278],"category_scores_gemma":[0.0016511204,0.00013889058,0.000837597,0.0002792815,0.00033119525,0.0004130554,0.00029132367,0.0016183833,0.0007395314],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.037518933,0.0014140237,0.29759693,0.00061652466,0.0008651555,0.31446856,0.00031598605,0.004548776,0.030975409,0.0033653819,0.033015408,0.27529892],"study_design_scores_gemma":[0.0036615839,0.0131417755,0.3355351,0.0007285284,0.002895016,0.5565027,0.001174006,0.011056547,0.012470819,0.010724492,0.051883798,0.00022568661],"about_ca_topic_score_codex":0.0027437077,"about_ca_topic_score_gemma":0.0080120275,"teacher_disagreement_score":0.0029639278,"about_ca_system_score_codex":0.0010316053,"about_ca_system_score_gemma":0.0009473676,"threshold_uncertainty_score":0.009915352},"labels":[],"label_agreement":null},{"id":"W2923839935","doi":"10.1016/j.ctarc.2019.100130","title":"Inpatients versus outpatients with advanced non-small cell lung cancer: Characteristics and outcomes","year":2019,"lang":"en","type":"article","venue":"Cancer Treatment and Research Communications","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Lung cancer; Medicine; Oncology; Cancer; Internal medicine; Intensive care medicine","score_opus":0.051103386016498616,"score_gpt":0.42214878576659487,"score_spread":0.37104539975009626,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2923839935","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9984018,0.0001711035,0.000023735587,0.00011048864,0.000015669097,0.0000100683255,0.0007305337,0.000001925916,0.00053457817],"genre_scores_gemma":[0.9986167,0.000090486494,0.00001620515,0.000070134185,0.000023059085,0.0000119809,0.00087703683,0.0000019019409,0.0002925397],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99919814,0.00010211115,0.00008537502,0.00014640759,0.00009614995,0.00037184553],"domain_scores_gemma":[0.9978115,0.00027951875,0.000944638,0.00004921027,0.00016917071,0.00074594084],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00047178738,0.00024511555,0.000564963,0.0010736054,0.00062450365,0.0010168934,0.0004683158,0.0008895907,0.0044725137],"category_scores_gemma":[0.00282279,0.00027144715,0.0008240364,0.001376522,0.00040744065,0.0014656648,0.0010564236,0.0011174153,0.0005906195],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00039091456,0.00014218863,0.9978676,0.000011397432,0.000039167826,0.00008769893,0.00015083494,0.000025265988,0.00007672433,0.000037649155,0.0002725806,0.00089804165],"study_design_scores_gemma":[0.000018933433,0.00024954823,0.99745995,0.000010900588,0.000018467379,0.00020244274,0.0016780149,0.000106948035,0.000021729822,0.00007316324,0.00015155827,0.000008320504],"about_ca_topic_score_codex":0.0069618803,"about_ca_topic_score_gemma":0.008181937,"teacher_disagreement_score":0.0069618803,"about_ca_system_score_codex":0.0007717354,"about_ca_system_score_gemma":0.00065619644,"threshold_uncertainty_score":0.014962077},"labels":[],"label_agreement":null},{"id":"W2972810294","doi":"10.1016/j.ctarc.2019.100160","title":"Adherence to guidelines for baseline staging in newly diagnosed localized breast cancer","year":2019,"lang":"en","type":"article","venue":"Cancer Treatment and Research Communications","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Essar Steel Algoma (Canada); Sault Area Hospital; NOSM University","funders":"","keywords":"Medicine; Breast cancer; Guideline; Cancer; Stage (stratigraphy); Cancer staging; Retrospective cohort study; Cohort; Internal medicine","score_opus":0.16547276914503498,"score_gpt":0.47950190672669807,"score_spread":0.31402913758166306,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2972810294","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"reporting","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":"reporting","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9938856,0.0013962751,0.00030222154,0.0010784928,0.000023331886,0.0001455843,0.0006337839,0.000016291138,0.0025184273],"genre_scores_gemma":[0.99837106,0.00038133404,0.00045334533,0.00014951518,0.000010738053,0.00003651351,0.00043751736,0.0000022703678,0.00015782194],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99583757,0.0010726629,0.0007171308,0.00029550123,0.0015797031,0.00049737573],"domain_scores_gemma":[0.9699052,0.0053731976,0.016398724,0.00092698314,0.0052928715,0.0021031294],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0030761226,0.00010633139,0.00025146763,0.00085461873,0.00076944544,0.00076844636,0.00080065825,0.0003580898,0.00074351515],"category_scores_gemma":[0.022537313,0.00011973963,0.00016247778,0.0017273666,0.00051696366,0.00030416087,0.0005102416,0.0004880525,0.00006794062],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000023296381,0.000038559127,0.991814,0.000055056065,0.000009808222,0.00005366163,0.00040131778,0.000059127407,0.00007773671,0.000028102944,0.00047099023,0.0069684265],"study_design_scores_gemma":[0.000003912045,0.000052894262,0.99795747,0.000084233805,0.0000075774287,0.00012053745,0.00069607445,0.00017031234,0.00007872725,0.00001569213,0.00080771657,0.0000048973643],"about_ca_topic_score_codex":0.34029925,"about_ca_topic_score_gemma":0.44843394,"teacher_disagreement_score":0.99692386,"about_ca_system_score_codex":0.0043740226,"about_ca_system_score_gemma":0.009498077,"threshold_uncertainty_score":0.67663693},"labels":[],"label_agreement":null},{"id":"W3025767822","doi":"10.1016/j.ctarc.2020.100178","title":"Salivary gland-type mammary carcinoma arising in microglandular adenosis: A case report and clinicopathological review of the literature","year":2020,"lang":"en","type":"review","venue":"Cancer Treatment and Research Communications","topic":"Salivary Gland Tumors Diagnosis and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of New Brunswick; University Health Network; Canada Research Chairs; University of Toronto; Sunnybrook Health Science Centre","funders":"Joseph and Silvana Melara Cancer Research Fund","keywords":"Medicine; Salivary gland; Mammary gland; Pathology; Myoepithelial cell; Carcinoma; Biopsy; Breast carcinoma; Radiation therapy; Oncology; Breast cancer; Cancer; Radiology; Internal medicine; Immunohistochemistry","score_opus":0.23925899124303776,"score_gpt":0.4932121560949287,"score_spread":0.2539531648518909,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3025767822","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.33246344,0.63879126,0.004795217,0.002988172,0.0019112065,0.00038363013,0.0005236731,0.0003790884,0.017764272],"genre_scores_gemma":[0.74120784,0.24642909,0.0032598537,0.0015711095,0.004392453,0.000103800674,0.00043477904,0.000043925404,0.002557074],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99955827,0.00005207097,0.00013008602,0.00009580076,0.000087042274,0.00007668512],"domain_scores_gemma":[0.9992772,0.00020239904,0.00026750684,0.00005521422,0.00008008019,0.00011763843],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034021618,0.001448903,0.0009924074,0.005939901,0.0011222637,0.001409875,0.0014355007,0.002122459,0.0020827586],"category_scores_gemma":[0.0011108133,0.0006236688,0.0005968613,0.0042308425,0.0013116796,0.0021281566,0.0011444227,0.00103603,0.0011799054],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000038345792,0.00006826912,0.013649013,0.0015166632,0.00006894578,0.95122963,0.00041133203,0.0001967063,0.0025971374,0.000309966,0.0033964552,0.026517404],"study_design_scores_gemma":[0.000004670676,0.000022991386,0.004908648,0.00023472334,0.00005580855,0.98709446,0.00029717517,0.000101459205,0.0002539572,0.00017391167,0.0068372167,0.000015027859],"about_ca_topic_score_codex":0.00074778567,"about_ca_topic_score_gemma":0.0012213134,"teacher_disagreement_score":0.005939901,"about_ca_system_score_codex":0.000506057,"about_ca_system_score_gemma":0.0006704352,"threshold_uncertainty_score":0.0069675446},"labels":[],"label_agreement":null},{"id":"W3036878031","doi":"10.1016/j.ctarc.2020.100185","title":"The impact of smoking on adjuvant breast cancer radiation treatment: A systematic review","year":2020,"lang":"en","type":"review","venue":"Cancer Treatment and Research Communications","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; Health Sciences Centre","funders":"Joseph and Silvana Melara Cancer Research Fund","keywords":"Medicine; Breast cancer; Radiation therapy; Internal medicine; Smoking cessation; MEDLINE; Adjuvant radiotherapy; Cancer; Quality of life (healthcare); Systematic review; Adjuvant; Oncology; Pathology","score_opus":0.13500641669959385,"score_gpt":0.49302904008085136,"score_spread":0.3580226233812575,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3036878031","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0012286297,0.9979779,0.00006296196,0.00014434282,0.000060160248,0.0001268511,0.00018141509,0.0000040070604,0.00021375109],"genre_scores_gemma":[0.012903543,0.9861746,0.0002470542,0.00024551016,0.00004611961,0.00018022185,0.00012189934,0.0000023750545,0.0000786738],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99634784,0.001276652,0.0011962462,0.00025583312,0.0008067431,0.00011671146],"domain_scores_gemma":[0.9858305,0.010486636,0.002320549,0.00014201317,0.0010734976,0.00014680397],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0038923095,0.0010224072,0.0053307894,0.0051994757,0.0005132444,0.001874851,0.0012966988,0.0015840199,0.003405911],"category_scores_gemma":[0.021890342,0.0007097891,0.006489201,0.006931043,0.0005247831,0.00147262,0.00090202544,0.0008948335,0.00024676282],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017066272,0.000019382756,0.0011968397,0.9515278,0.008767835,0.00010328616,0.00013717057,0.00009718404,0.000119179625,0.000113365735,0.0010643278,0.03668304],"study_design_scores_gemma":[0.0002049543,0.0002802692,0.008258175,0.88010997,0.09297683,0.0005560343,0.000249473,0.00014048564,0.00018490385,0.00022776902,0.016774287,0.000036799796],"about_ca_topic_score_codex":0.008977614,"about_ca_topic_score_gemma":0.025671823,"teacher_disagreement_score":0.008977614,"about_ca_system_score_codex":0.0022683472,"about_ca_system_score_gemma":0.0074293646,"threshold_uncertainty_score":0.020584702},"labels":[],"label_agreement":null},{"id":"W3097450343","doi":"10.1016/j.ctarc.2020.100233","title":"Nutritional outcomes in head and neck cancer patients: is intensive nutritional care worth it?","year":2020,"lang":"en","type":"article","venue":"Cancer Treatment and Research Communications","topic":"Nutrition and Health in Aging","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research; University of Toronto; Princess Margaret Cancer Centre","funders":"","keywords":"Head and neck cancer; Medicine; Head and neck; Intensive care medicine; Head (geology); Cancer; Gerontology; Internal medicine; Surgery","score_opus":0.25699926979951065,"score_gpt":0.5041243990798802,"score_spread":0.2471251292803695,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3097450343","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99739885,0.0016077898,0.000039522572,0.00035127488,0.000016047887,0.00001532824,0.00009946668,0.0000015249818,0.00047020504],"genre_scores_gemma":[0.9993482,0.0003201145,0.000054259614,0.000067244866,0.000022703834,0.0000087534,0.00011861803,6.7805564e-7,0.00005934367],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993119,0.00022645827,0.000101392245,0.00008059339,0.00017047342,0.000109191875],"domain_scores_gemma":[0.9972224,0.00047296914,0.0017191514,0.000045753055,0.000192584,0.00034722197],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010379431,0.00010367305,0.00033780516,0.00035002624,0.0003105137,0.0006180021,0.00020460755,0.00031929094,0.0009598429],"category_scores_gemma":[0.004612625,0.00006504969,0.00029155373,0.00073248,0.00025132357,0.0006092974,0.00049445854,0.00048405686,0.0000885999],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00086904876,0.00027588816,0.975604,0.00014849703,0.00011728143,0.00006701397,0.00016150098,0.00006686025,0.00015510128,0.000020301542,0.00019038397,0.022324128],"study_design_scores_gemma":[0.000021084074,0.0006356922,0.9982211,0.000060265647,0.000077595454,0.000093892384,0.0004340008,0.000076637996,0.00007584944,0.000030115112,0.00026945953,0.000004333151],"about_ca_topic_score_codex":0.002729162,"about_ca_topic_score_gemma":0.005040124,"teacher_disagreement_score":0.002729162,"about_ca_system_score_codex":0.00050106563,"about_ca_system_score_gemma":0.00071938557,"threshold_uncertainty_score":0.00548923},"labels":[],"label_agreement":null},{"id":"W3107142083","doi":"10.1016/j.ctarc.2020.100246","title":"The impact of synchronous malignancies on survival in patients with early stage curable non-small-cell lung cancer","year":2020,"lang":"en","type":"article","venue":"Cancer Treatment and Research Communications","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Juravinski Cancer Centre; Sunnybrook Health Science Centre; Health Sciences Centre; Cancer Care Ontario; McMaster University; University Health Network; University of Toronto","funders":"Government of Ontario; Cancer Care Ontario","keywords":"Stage (stratigraphy); Lung cancer; Oncology; Medicine; Internal medicine; Cancer; Overall survival; Biology","score_opus":0.07345195613966087,"score_gpt":0.3851385666671447,"score_spread":0.3116866105274838,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3107142083","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9986614,0.00043093372,0.000044753495,0.00010601414,0.0000043088153,0.0000029996957,0.00021320076,0.0000021717883,0.00053419295],"genre_scores_gemma":[0.99971896,0.00007543302,0.000018893013,0.0000107846845,0.000005236453,9.12033e-7,0.0001292748,4.940059e-7,0.000040035968],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99969244,0.000050687835,0.000017470302,0.000043108234,0.00009334282,0.000102909136],"domain_scores_gemma":[0.9981996,0.0003559103,0.00077020016,0.00006843397,0.00018380649,0.00042192198],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032280805,0.00016791624,0.00021803926,0.00029844488,0.00034824086,0.00048483195,0.00023099294,0.0002444434,0.0018070653],"category_scores_gemma":[0.002784699,0.00009234546,0.00040711102,0.0005231246,0.00022368685,0.00028023127,0.00040916298,0.00035566385,0.00010999482],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001275687,0.000009846147,0.9974528,0.0000072345892,0.00001964524,0.00006965062,0.000014501137,0.00010465502,0.00007490693,0.000012760844,0.00008212744,0.0020242664],"study_design_scores_gemma":[0.0000040852196,0.00003497486,0.9994351,0.0000035255102,0.000016129292,0.00019076379,0.00003574937,0.00017762615,0.000020141531,0.000019879084,0.000060933922,0.000001045691],"about_ca_topic_score_codex":0.029408284,"about_ca_topic_score_gemma":0.077823825,"teacher_disagreement_score":0.029408284,"about_ca_system_score_codex":0.0013457572,"about_ca_system_score_gemma":0.0011792773,"threshold_uncertainty_score":0.058474183},"labels":[],"label_agreement":null},{"id":"W3108071574","doi":"10.1016/j.ctarc.2020.100265","title":"Applicability of the PACIFIC trial results in patients not eligible for the PACIFIC trial: Canadian rapid consensus statement and recommendations.","year":2020,"lang":"en","type":"article","venue":"Cancer Treatment and Research Communications","topic":"Lung Cancer Diagnosis and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université de Montréal; University of Ottawa; University of Toronto; Dalhousie University; University of British Columbia; McMaster University; Queen's University","funders":"","keywords":"Durvalumab; Medicine; Clinical trial; Family medicine; Intensive care medicine; Cancer; Internal medicine","score_opus":0.1934078137220699,"score_gpt":0.4404405117552331,"score_spread":0.2470326980331632,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3108071574","genre_codex":"commentary","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00431734,0.04954743,0.020601057,0.80290085,0.018934788,0.041218158,0.012116469,0.00045640682,0.049907587],"genre_scores_gemma":[0.1074014,0.041671548,0.25659665,0.44817913,0.009825236,0.09971191,0.018147277,0.00074967556,0.017717233],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.64316255,0.21757324,0.06092952,0.0064987126,0.06426434,0.007571645],"domain_scores_gemma":[0.31838226,0.36513746,0.043676227,0.026186613,0.22376604,0.022851467],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.5092359,0.0015584216,0.0035113818,0.0036817258,0.0043649445,0.009698981,0.013812885,0.020252721,0.0051480983],"category_scores_gemma":[0.57739604,0.0016476271,0.006120733,0.0058844793,0.006195397,0.004939921,0.0068301335,0.017040605,0.0026632752],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0028640432,0.00016881271,0.0049675647,0.033409767,0.0017206487,0.00036094536,0.0045733224,0.0016850872,0.00091895874,0.01633506,0.73820674,0.194789],"study_design_scores_gemma":[0.0055761966,0.00048998964,0.009675632,0.07331398,0.0024804245,0.00027631238,0.0019149231,0.0023098446,0.0011198387,0.022187946,0.88013333,0.0005216842],"about_ca_topic_score_codex":0.17921132,"about_ca_topic_score_gemma":0.1981891,"teacher_disagreement_score":0.8207887,"about_ca_system_score_codex":0.028844565,"about_ca_system_score_gemma":0.25450715,"threshold_uncertainty_score":0.6051995},"labels":[],"label_agreement":null},{"id":"W3109289476","doi":"10.1016/j.ctarc.2020.100244","title":"Cancer-related fatigue in head and neck cancer survivors: Energy and functional impacts","year":2020,"lang":"en","type":"article","venue":"Cancer Treatment and Research Communications","topic":"Cancer survivorship and care","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Children's Hospital; Alberta Health Services; University of Alberta","funders":"","keywords":"Head and neck cancer; Thematic analysis; Cancer; Exploratory research; Quality of life (healthcare); Cancer survivor; Medicine; Cancer-related fatigue; Exploratory analysis; Energy (signal processing); Clinical psychology; Psychology; Physical therapy; Gerontology; Internal medicine; Qualitative research; Nursing; Data science; Computer science","score_opus":0.19012865019185046,"score_gpt":0.42864773554791513,"score_spread":0.23851908535606467,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3109289476","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9973521,0.000692559,0.00007651238,0.0003363029,0.000009193115,0.000031967516,0.00014186346,0.0000030502554,0.0013565104],"genre_scores_gemma":[0.9989291,0.00049754116,0.00008063631,0.0000812748,0.0000060886373,0.000031024272,0.00010336503,9.172519e-7,0.0002700763],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99970585,0.00015184695,0.000025571495,0.000017637036,0.000047805697,0.000051227362],"domain_scores_gemma":[0.99922764,0.00030343706,0.00023676096,0.000018427352,0.00011859151,0.00009501327],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00070995826,0.00011227777,0.00015342276,0.0003132967,0.0005072639,0.00037892445,0.000121784586,0.00024532105,0.0021335932],"category_scores_gemma":[0.0028008032,0.000051068197,0.0001751936,0.000424449,0.00031642636,0.0003294993,0.0004941664,0.00023263448,0.000108444074],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00030124348,0.0001797521,0.8820123,0.0008638338,0.00007845189,0.00074722344,0.03435655,0.0002805152,0.0021678736,0.00015405584,0.0021963972,0.076661885],"study_design_scores_gemma":[0.0000092377495,0.00054409995,0.94819736,0.00022528027,0.00004155055,0.00083099364,0.046363205,0.00016400167,0.00034309886,0.00012541043,0.0031410027,0.00001467512],"about_ca_topic_score_codex":0.0039624018,"about_ca_topic_score_gemma":0.009555165,"teacher_disagreement_score":0.0039624018,"about_ca_system_score_codex":0.0003394851,"about_ca_system_score_gemma":0.0005902323,"threshold_uncertainty_score":0.007878661},"labels":[],"label_agreement":null},{"id":"W3109625109","doi":"10.1016/j.ctarc.2020.100249","title":"Association between continuous decrease of plasma VEGF-A levels and the efficacy of chemotherapy in combination with anti-programmed cell death 1 antibody in non-small cell lung cancer patients","year":2020,"lang":"en","type":"article","venue":"Cancer Treatment and Research Communications","topic":"Angiogenesis and VEGF in Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Daiichi Sankyo Company; Eli Lilly Japan; Chugai Pharmaceutical; Pfizer Japan; MSD K.K.; Eisai; Ono Pharmaceutical; Bristol-Myers Squibb Canada; Novartis; Otsuka Pharmaceutical; Astellas Pharma; Kyowa Hakko Kirin; Taiho Pharmaceutical; AstraZeneca","keywords":"Lung cancer; Vascular endothelial growth factor; Medicine; Chemotherapy; Internal medicine; Oncology; Antibody; Cancer; VEGF receptors; Gastroenterology; Immunology","score_opus":0.039500060705252166,"score_gpt":0.3540200462152083,"score_spread":0.3145199855099561,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3109625109","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99918276,0.0004636635,0.000059007853,0.000019724443,0.000005247644,0.000005761046,0.000055967444,0.0000027671524,0.00020513119],"genre_scores_gemma":[0.9997178,0.000055312838,0.00004609869,0.0000098157825,0.000009577369,0.0000067892024,0.00007974001,7.4343586e-7,0.00007414229],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99965274,0.00009480238,0.00004869121,0.00008564077,0.00006878463,0.00004934449],"domain_scores_gemma":[0.9981744,0.00056745065,0.0007349053,0.0000622106,0.00014538925,0.00031562612],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00042643136,0.00017108391,0.0003737796,0.0003020545,0.00024251083,0.0003391687,0.00019533785,0.00044919914,0.0008389242],"category_scores_gemma":[0.0015995831,0.00017611429,0.0002643535,0.00038961243,0.0001698358,0.00026752593,0.00017161245,0.0005249062,0.0001273805],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017831447,0.00009949461,0.9940871,0.000012814719,0.000066691224,0.00014487815,0.000018346962,0.00013466192,0.0013924197,0.000009604255,0.000048398142,0.0022024568],"study_design_scores_gemma":[0.000056614845,0.001356012,0.99667287,0.0000051961842,0.000056565303,0.0006397759,0.000038086804,0.0006134057,0.00033579773,0.000017134602,0.0002037255,0.0000047417584],"about_ca_topic_score_codex":0.00044466002,"about_ca_topic_score_gemma":0.0006780522,"teacher_disagreement_score":0.0008389242,"about_ca_system_score_codex":0.00023441012,"about_ca_system_score_gemma":0.00021207758,"threshold_uncertainty_score":0.0028065443},"labels":[],"label_agreement":null},{"id":"W3111935365","doi":"10.1016/j.ctarc.2020.100287","title":"Salvage surgery for locally recurrent anal cancer after intensity modulated radiation therapy with concurrent chemotherapy","year":2020,"lang":"en","type":"article","venue":"Cancer Treatment and Research Communications","topic":"Colorectal and Anal Carcinomas","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; University of Toronto; Health Sciences Centre","funders":"","keywords":"Medicine; Surgery; Salvage therapy; Salvage surgery; Radiation therapy; Anal cancer; Cancer; Chemotherapy; Internal medicine","score_opus":0.17769726650268317,"score_gpt":0.4121883678049259,"score_spread":0.23449110130224274,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3111935365","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9942819,0.003212683,0.0006505574,0.00010122082,0.000020190082,0.000035652276,0.00013293202,0.000062986,0.0015020281],"genre_scores_gemma":[0.9977174,0.001229664,0.00038609546,0.00007502727,0.000030160747,0.000010654969,0.00020002594,0.000008476996,0.00034254283],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99965894,0.00006877234,0.000056757828,0.00004817521,0.00009911909,0.000068186804],"domain_scores_gemma":[0.99845374,0.00029588223,0.0008663971,0.000105098276,0.00009042135,0.00018846236],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00042075047,0.00027575484,0.00048521382,0.0007787814,0.00043910477,0.0006008089,0.0004274171,0.00027336515,0.0024214103],"category_scores_gemma":[0.0016158004,0.00012879987,0.00054082804,0.00083055213,0.00039598512,0.00027477642,0.0004518373,0.0004135792,0.00051477307],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00042901872,0.00015704425,0.88573027,0.00037926307,0.00016589883,0.03588172,0.0006002986,0.00039787652,0.0045260848,0.00011262432,0.0009994566,0.070620455],"study_design_scores_gemma":[0.00004812761,0.0024244043,0.7365777,0.0003160022,0.00021149911,0.24869229,0.0008648586,0.0006651851,0.0065266863,0.00021628292,0.0034297071,0.000027131618],"about_ca_topic_score_codex":0.00066212803,"about_ca_topic_score_gemma":0.0013804303,"teacher_disagreement_score":0.0024214103,"about_ca_system_score_codex":0.0004936624,"about_ca_system_score_gemma":0.00053973857,"threshold_uncertainty_score":0.00810039},"labels":[],"label_agreement":null},{"id":"W3117695288","doi":"10.1016/j.ctarc.2020.100294","title":"Chemotherapy for Non-Small Cell Lung Cancer in the Intensive Care Unit","year":2020,"lang":"en","type":"article","venue":"Cancer Treatment and Research Communications","topic":"Lung Cancer Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Pemetrexed; Medicine; Chemotherapy; Intensive care unit; Lung cancer; Malignancy; Cisplatin; Adenocarcinoma; Intensive care; Oncology; Intensive care medicine; Internal medicine; Cancer","score_opus":0.14625037072315633,"score_gpt":0.45689690989330056,"score_spread":0.31064653917014423,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3117695288","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9643232,0.012472783,0.0011943562,0.004579069,0.00043034754,0.00023269159,0.00019598259,0.00008653803,0.016485],"genre_scores_gemma":[0.99336034,0.0031038523,0.00054524414,0.0012727347,0.00043227812,0.00005893198,0.000172286,0.0000074941395,0.0010468926],"study_design_codex":"case_report","study_design_gemma":"observational","domain_scores_codex":[0.99983,0.000049861766,0.000023349112,0.000020455716,0.000028719705,0.00004758764],"domain_scores_gemma":[0.99936014,0.00013892997,0.00016295373,0.000024453866,0.000050131737,0.00026338216],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012803554,0.00021959213,0.00039662587,0.00028819262,0.0010094595,0.0003896845,0.00039164562,0.0006169821,0.0023814554],"category_scores_gemma":[0.0013121563,0.00010213814,0.0002928902,0.00043251706,0.00029276792,0.00027770936,0.00035343002,0.0007147633,0.00040086915],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010762835,0.0007581362,0.4168405,0.0008861638,0.00013811234,0.49752477,0.0011794324,0.00072531454,0.010015406,0.0006485137,0.012276347,0.05793114],"study_design_scores_gemma":[0.00031563453,0.0038593248,0.36198914,0.0007296516,0.00020645572,0.6003752,0.00111539,0.0020146086,0.0048754998,0.00090485153,0.023562394,0.0000518845],"about_ca_topic_score_codex":0.00077350246,"about_ca_topic_score_gemma":0.0017472093,"teacher_disagreement_score":0.0023814554,"about_ca_system_score_codex":0.00055498246,"about_ca_system_score_gemma":0.00063242496,"threshold_uncertainty_score":0.007966697},"labels":[],"label_agreement":null},{"id":"W3126798229","doi":"10.1016/j.ctarc.2021.100330","title":"A single institution study evaluating outcomes of PD-L1 high KRAS-mutant advanced non-small cell lung cancer (NSCLC) patients treated with first line immune checkpoint inhibitors","year":2021,"lang":"en","type":"article","venue":"Cancer Treatment and Research Communications","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Kingston Health Sciences Centre; Queen's University","funders":"","keywords":"KRAS; Medicine; Internal medicine; Oncology; Lung cancer; Cancer; Adverse effect; Colorectal cancer","score_opus":0.0786849360391814,"score_gpt":0.40058061211302104,"score_spread":0.3218956760738396,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3126798229","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99931335,0.00016737868,0.000057486403,0.000022366907,0.0000037237317,0.000031904285,0.00019319388,0.0000025824745,0.00020817446],"genre_scores_gemma":[0.99951434,0.00006178516,0.00006147032,0.000032240856,0.000009374656,0.000018953078,0.00023722652,0.0000013604932,0.00006315765],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991172,0.0002675431,0.00008753518,0.00024886228,0.00015968936,0.00011912291],"domain_scores_gemma":[0.9976935,0.0003387195,0.0010365859,0.00015988055,0.00023508315,0.00053613447],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008251384,0.00025296552,0.00057032844,0.00041471046,0.00054202037,0.0008670197,0.00033726037,0.00031219795,0.001452849],"category_scores_gemma":[0.0018714773,0.000269181,0.00063102244,0.00080742006,0.00043639078,0.0004529279,0.00050270336,0.00046127528,0.00025817004],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001351839,0.00017975947,0.99555737,0.00003243866,0.0001781447,0.0000970716,0.00007330808,0.00004556876,0.00040014746,0.000011237111,0.000100356156,0.0019726974],"study_design_scores_gemma":[0.00027433594,0.003014671,0.99481744,0.000021054806,0.00024595187,0.0004886823,0.00024578348,0.00021666398,0.00022662967,0.000017664543,0.00042136974,0.000009733513],"about_ca_topic_score_codex":0.005849764,"about_ca_topic_score_gemma":0.011992917,"teacher_disagreement_score":0.005849764,"about_ca_system_score_codex":0.0015086369,"about_ca_system_score_gemma":0.0014478926,"threshold_uncertainty_score":0.011631429},"labels":[],"label_agreement":null},{"id":"W3137491601","doi":"10.1016/j.ctarc.2021.100353","title":"Discordance in PD-L1 scores on repeat testing of non-small cell lung carcinomas","year":2021,"lang":"en","type":"article","venue":"Cancer Treatment and Research Communications","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC; University of British Columbia","funders":"","keywords":"Medicine; Internal medicine; Oncology; Pleural effusion; Carcinoma; Biopsy; Retrospective cohort study; Malignant pleural effusion; Pathology","score_opus":0.14059017514654282,"score_gpt":0.4125888941020173,"score_spread":0.2719987189554745,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3137491601","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9976478,0.0005664383,0.00083425967,0.000032058033,0.000010881451,0.00003136296,0.00019170596,0.000029387147,0.0006561785],"genre_scores_gemma":[0.999268,0.00006309832,0.0004202936,0.00001641397,0.000007234814,0.000008997441,0.00015208269,0.000005261592,0.000058605987],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99339974,0.0017533139,0.0011270264,0.0008201747,0.0025653704,0.0003344347],"domain_scores_gemma":[0.9805658,0.008555321,0.006665306,0.0013939505,0.0024856075,0.00033401078],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005449502,0.00032775052,0.00051639456,0.0017658729,0.00036202118,0.00076330977,0.00088205904,0.00043929464,0.00074424985],"category_scores_gemma":[0.019937024,0.00025876518,0.00029001813,0.0009856491,0.00061448134,0.00040994087,0.000588567,0.00037076848,0.00025872572],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022735391,0.000020785386,0.99103326,0.000042017124,0.000047672787,0.0007336087,0.00023264094,0.00012616723,0.001960495,0.00002448753,0.00012469389,0.0054268045],"study_design_scores_gemma":[0.000008691091,0.00022761758,0.9790413,0.000027177812,0.000072599236,0.0073080496,0.00024411768,0.0011174801,0.0112195825,0.00006766244,0.0006540939,0.000011576363],"about_ca_topic_score_codex":0.0014660744,"about_ca_topic_score_gemma":0.0011757626,"teacher_disagreement_score":0.005449502,"about_ca_system_score_codex":0.00073537836,"about_ca_system_score_gemma":0.00033095223,"threshold_uncertainty_score":0.028820097},"labels":[],"label_agreement":null},{"id":"W3146059679","doi":"10.1016/j.ctarc.2021.100363","title":"Endometrial Stem/Progenitor cell (ES/PC) Marker Expression Profile in Adenosarcoma and Endometrial Stromal Sarcoma","year":2021,"lang":"en","type":"article","venue":"Cancer Treatment and Research Communications","topic":"Uterine Myomas and Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital; Toronto General Hospital; University of Toronto; McGill University Health Centre; St. Michael's Hospital","funders":"","keywords":"Stromal cell; Biology; Stem cell; Progenitor cell; Cancer research; Carcinogenesis; Endometrial stromal sarcoma; Cell biology; Cancer; Genetics","score_opus":0.12408277140251638,"score_gpt":0.4087666330982965,"score_spread":0.2846838616957801,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3146059679","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9984517,0.00045595213,0.0005193912,0.000005961773,0.0000012498725,0.0000082365505,0.00019935398,0.000009895809,0.000348109],"genre_scores_gemma":[0.9973328,0.00029311137,0.0016780905,0.000007900977,0.0000017329677,0.000015178491,0.00044960593,0.0000044663893,0.00021703682],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9998946,0.000012467959,0.00001775915,0.00003024124,0.000029041557,0.000015816706],"domain_scores_gemma":[0.99984705,0.00002700113,0.000054289234,0.000015269292,0.000031821237,0.000024609226],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017973265,0.00012685987,0.00015373777,0.0008865631,0.00014568603,0.00023005859,0.000076921904,0.00014495634,0.0006637818],"category_scores_gemma":[0.00028761293,0.000121144665,0.00011422167,0.00059055927,0.00024179352,0.00011735743,0.0002160036,0.000114533934,0.00019362794],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00092496607,0.000028908731,0.2752672,0.00022133694,0.000085518164,0.00058195955,0.00035897986,0.00044469238,0.7090748,0.00016288347,0.00012485981,0.012723853],"study_design_scores_gemma":[0.00001779814,0.00033128765,0.8098681,0.000022252112,0.00013986458,0.004392491,0.0005541567,0.0025874667,0.17915234,0.000221978,0.00269204,0.000020172245],"about_ca_topic_score_codex":0.0003889044,"about_ca_topic_score_gemma":0.00062374905,"teacher_disagreement_score":0.0008865631,"about_ca_system_score_codex":0.00013008031,"about_ca_system_score_gemma":0.00013572136,"threshold_uncertainty_score":0.002220571},"labels":[],"label_agreement":null},{"id":"W3155354072","doi":"10.1016/j.ctarc.2021.100376","title":"Proteomic signatures of radioresistance: Alteration of inflammation, angiogenesis and metabolism-related factors in radioresistant oesophageal adenocarcinoma","year":2021,"lang":"en","type":"article","venue":"Cancer Treatment and Research Communications","topic":"Esophageal Cancer Research and Treatment","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Trinity College","funders":"Science Foundation Ireland","keywords":"Radioresistance; Cancer research; Biology; Angiogenesis; Proteomics; Radiation therapy; Bioinformatics; Medicine; Internal medicine; Gene; Genetics","score_opus":0.05448878591090385,"score_gpt":0.374296516555609,"score_spread":0.3198077306447052,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3155354072","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99664706,0.0016894285,0.0008062695,0.000028585144,0.0000069761372,0.0000133977155,0.00045821516,0.000010552515,0.00033938917],"genre_scores_gemma":[0.99517727,0.0016812482,0.0010527612,0.000044632463,0.000006935265,0.00003142383,0.001314289,0.0000051074026,0.0006864482],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9999373,0.000011922631,0.0000075066264,0.000014495228,0.000017308987,0.00001144065],"domain_scores_gemma":[0.99993944,0.000007777608,0.000023563876,0.0000064960486,0.000012292537,0.000010394704],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014634014,0.0002268032,0.00025255608,0.00054070074,0.00012967535,0.00034395963,0.00007759987,0.00019023512,0.0005525906],"category_scores_gemma":[0.00013850967,0.0000896548,0.00021147485,0.00047369447,0.000121937395,0.00018374252,0.00018327586,0.00016111291,0.00014603946],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00033934167,0.000025254205,0.007851638,0.00009389628,0.00003222856,0.0001717846,0.000052751115,0.00006675868,0.9887376,0.000040562918,0.00004267575,0.0025455456],"study_design_scores_gemma":[0.000029580493,0.0008348417,0.7469146,0.000026359185,0.000208055,0.002910136,0.00040205516,0.0016062189,0.24238472,0.00019234017,0.00446859,0.00002249198],"about_ca_topic_score_codex":0.00032455218,"about_ca_topic_score_gemma":0.00035750703,"teacher_disagreement_score":0.0005525906,"about_ca_system_score_codex":0.00009397476,"about_ca_system_score_gemma":0.00009764731,"threshold_uncertainty_score":0.001848638},"labels":[],"label_agreement":null},{"id":"W3156170207","doi":"10.1016/j.ctarc.2021.100378","title":"RELAY, ramucirumab plus erlotinib versus placebo plus erlotinib in patients with untreated, EGFR-mutated, metastatic non-small cell lung cancer: Europe/United States subset analysis","year":2021,"lang":"en","type":"article","venue":"Cancer Treatment and Research Communications","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Eli Lilly and Company","keywords":"Erlotinib; Ramucirumab; Internal medicine; Medicine; Placebo; Population; Oncology; Lung cancer; Subgroup analysis; Gastroenterology; Cancer; Epidermal growth factor receptor; Pathology; Confidence interval","score_opus":0.060560401384030245,"score_gpt":0.4003621795605682,"score_spread":0.33980177817653795,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3156170207","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9962218,0.0017800842,0.00019823686,0.00008814039,0.000034982673,0.00029622,0.0007589432,0.000025612184,0.00059598126],"genre_scores_gemma":[0.9968394,0.0007387329,0.00024457468,0.00016639683,0.000055183573,0.0002838653,0.001104338,0.0000065862887,0.0005610353],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9990435,0.0006649167,0.000060124286,0.000102182436,0.000055945293,0.00007318377],"domain_scores_gemma":[0.99934,0.00018838121,0.00021067656,0.000071228256,0.00005201999,0.00013772502],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002388569,0.0010252681,0.0019854666,0.0004111138,0.00017623793,0.0006659825,0.00055907323,0.0004695128,0.0024151327],"category_scores_gemma":[0.001375961,0.00038484271,0.00350378,0.00039977196,0.00032654597,0.00050994504,0.00037511947,0.0007896022,0.00030936484],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9566326,0.0016107596,0.0123217935,0.00037766906,0.00945532,0.00009247996,0.0000696336,0.001191019,0.0031603936,0.00008873225,0.0010384048,0.013961175],"study_design_scores_gemma":[0.5373918,0.2837205,0.13212632,0.00017777232,0.031999074,0.0007424819,0.00025568472,0.005456795,0.003481707,0.0006092841,0.003953185,0.000085453066],"about_ca_topic_score_codex":0.00068612566,"about_ca_topic_score_gemma":0.0017659856,"teacher_disagreement_score":0.0024151327,"about_ca_system_score_codex":0.0005759019,"about_ca_system_score_gemma":0.00052569556,"threshold_uncertainty_score":0.012632072},"labels":[],"label_agreement":null},{"id":"W3164270701","doi":"10.1016/j.ctarc.2021.100401","title":"Developing a clinical-pathologic model to predict genomic risk of recurrence in patients with hormone receptor positive, human epidermal growth factor receptor-2 negative, node negative breast cancer","year":2021,"lang":"en","type":"article","venue":"Cancer Treatment and Research Communications","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Manitoba; University of Alberta; University of Calgary","funders":"","keywords":"Internal medicine; Medicine; Breast cancer; Oncology; Odds ratio; Logistic regression; Confidence interval; Hormone receptor; Cancer","score_opus":0.08719592673020116,"score_gpt":0.3966071531470477,"score_spread":0.30941122641684654,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3164270701","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95762825,0.00059134833,0.036996868,0.001549097,0.00006853552,0.0001892366,0.0012571323,0.0002203241,0.001499398],"genre_scores_gemma":[0.9925849,0.00010669779,0.005625202,0.00007622294,0.000039587972,0.00009448178,0.00088881975,0.000013748532,0.0005701802],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9985977,0.000885841,0.000067309426,0.000196726,0.0001318126,0.00012066379],"domain_scores_gemma":[0.99226874,0.0061302106,0.00064049516,0.00015671583,0.00050010206,0.0003036489],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006647026,0.001084325,0.0007057868,0.0017739792,0.0003822108,0.0014041649,0.0011108012,0.00066437485,0.0018746521],"category_scores_gemma":[0.010807146,0.00041898017,0.001404201,0.0006402401,0.00034226262,0.00052463537,0.0008914065,0.00093420036,0.0003859994],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001457756,0.00038791815,0.856565,0.00007038482,0.0010172144,0.00020604397,0.00009411616,0.1171742,0.0003688091,0.0006029978,0.001547722,0.020507893],"study_design_scores_gemma":[0.00009600372,0.00046631522,0.053933248,0.000025594387,0.0004910529,0.00025537686,0.00007360096,0.94271564,0.0001725192,0.001203914,0.0005465911,0.000020116104],"about_ca_topic_score_codex":0.009896475,"about_ca_topic_score_gemma":0.0055768066,"teacher_disagreement_score":0.009896475,"about_ca_system_score_codex":0.0009386846,"about_ca_system_score_gemma":0.0016796412,"threshold_uncertainty_score":0.03515321},"labels":[],"label_agreement":null},{"id":"W3164647557","doi":"10.1016/j.ctarc.2021.100403","title":"Predictive factors associated with radiation dermatitis in breast cancer","year":2021,"lang":"en","type":"article","venue":"Cancer Treatment and Research Communications","topic":"Effects of Radiation Exposure","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Internal medicine; Erythema; Breast cancer; Univariate analysis; Radiation therapy; Edema; Gastroenterology; Cancer; Surgery; Multivariate analysis","score_opus":0.07153526143740871,"score_gpt":0.404114585665896,"score_spread":0.33257932422848724,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3164647557","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9963637,0.0015945935,0.00022591076,0.00020819003,0.000022217208,0.000017563765,0.00022869583,0.000013008886,0.0013262264],"genre_scores_gemma":[0.9992816,0.00024335012,0.00017193766,0.00002531784,0.00001848266,0.000007050062,0.00012321498,0.0000028343131,0.00012623094],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995678,0.00012987429,0.00006575962,0.000051002207,0.00012926153,0.000056232435],"domain_scores_gemma":[0.99665135,0.0010155512,0.0016392799,0.000110367415,0.00024843094,0.00033506288],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00054477504,0.00020398304,0.00021271549,0.0005955901,0.00032246017,0.00044694293,0.00024780256,0.0003140419,0.0027622604],"category_scores_gemma":[0.004347504,0.0001179201,0.0003815019,0.0009374995,0.00025939755,0.00021053047,0.0002728782,0.0006526868,0.00025536725],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000046876874,0.000018904077,0.9983364,0.000011926973,0.000012676091,0.00004385306,0.000011143008,0.00004767515,0.00010421763,0.000005036375,0.00006398663,0.0012973355],"study_design_scores_gemma":[0.0000024629512,0.00007714765,0.9985421,0.000010076945,0.000024263594,0.00062439614,0.00008735073,0.00017865322,0.00010408881,0.000020422238,0.00032652056,0.0000025686322],"about_ca_topic_score_codex":0.0013792765,"about_ca_topic_score_gemma":0.0020041086,"teacher_disagreement_score":0.0027622604,"about_ca_system_score_codex":0.00024756734,"about_ca_system_score_gemma":0.0004086952,"threshold_uncertainty_score":0.009240687},"labels":[],"label_agreement":null},{"id":"W3169117957","doi":"10.1016/j.ctarc.2021.100414","title":"Practical management and assessment of primary plasma cell leukemia in the novel agent era","year":2021,"lang":"en","type":"review","venue":"Cancer Treatment and Research Communications","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"National Cancer Institute","keywords":"Plasma cell leukemia; Malignancy; Medicine; Multiple myeloma; Leukemia; Clinical trial; Oncology; Internal medicine","score_opus":0.40737040633907273,"score_gpt":0.5537650122771408,"score_spread":0.14639460593806808,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3169117957","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000105860905,0.99814,0.00015615311,0.00055581954,0.00016303487,0.0000075808243,0.000017305512,0.0000052203454,0.0008490234],"genre_scores_gemma":[0.0010879398,0.9974221,0.00039925173,0.000410955,0.00017304772,0.000012117479,0.0000463716,0.0000014073618,0.00044686493],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997503,0.00007028153,0.00004376466,0.000026619771,0.00009065195,0.000018304505],"domain_scores_gemma":[0.99961865,0.00017045239,0.000070122514,0.000008197453,0.00011002076,0.000022567292],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008095222,0.00061592954,0.0013479379,0.0020040418,0.00021080827,0.0009579038,0.00075833715,0.0011696267,0.0031513222],"category_scores_gemma":[0.0012636068,0.00021953433,0.00068838336,0.0011506841,0.00032026257,0.0012241686,0.00056603615,0.0016942902,0.0012966489],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009353971,0.000046882054,0.00021414741,0.02467417,0.00010478089,0.0003367226,0.000069083566,0.00029773076,0.000953939,0.003044756,0.036669645,0.9334947],"study_design_scores_gemma":[0.00005686837,0.0001232123,0.001733221,0.018978914,0.0002636354,0.0042441506,0.0001566571,0.000175931,0.0005632923,0.004391961,0.96928185,0.000030310222],"about_ca_topic_score_codex":0.0013254061,"about_ca_topic_score_gemma":0.0023829194,"teacher_disagreement_score":0.0031513222,"about_ca_system_score_codex":0.00066559156,"about_ca_system_score_gemma":0.0012899013,"threshold_uncertainty_score":0.010542214},"labels":[],"label_agreement":null},{"id":"W3170157402","doi":"10.1016/j.ctarc.2021.100421","title":"A phase I/II study of pembrolizumab in combination with nab-paclitaxel in patients with unresectable stage III or stage IV non small-cell lung carcinoma (NSCLC)","year":2021,"lang":"en","type":"article","venue":"Cancer Treatment and Research Communications","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University; Centre Hospitalier de l’Université de Montréal","funders":"Merck","keywords":"Stage (stratigraphy); Pembrolizumab; Medicine; Oncology; Internal medicine; Paclitaxel; Nab-paclitaxel; Carcinoma; Chemotherapy; Cancer; Immunotherapy; Biology","score_opus":0.07057552295191545,"score_gpt":0.3883166627883285,"score_spread":0.31774113983641306,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3170157402","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9911293,0.0022907758,0.0005408822,0.00072392845,0.00025831844,0.0022365428,0.0009170498,0.00007957144,0.0018237592],"genre_scores_gemma":[0.9854929,0.0032834206,0.0018615358,0.0010943165,0.00031016013,0.0031150817,0.0020031335,0.00004733309,0.002792269],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.999514,0.00021404843,0.00002039773,0.00010110768,0.000035113582,0.00011535512],"domain_scores_gemma":[0.9992895,0.00011403637,0.00008840667,0.00006421364,0.000039392926,0.00040441548],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001581823,0.0018660227,0.003002507,0.0006614834,0.0005937908,0.0013378303,0.0011904814,0.0015281971,0.0037271741],"category_scores_gemma":[0.0009810176,0.0010201742,0.0020604841,0.0006332431,0.0013878524,0.0013073188,0.00041898497,0.0045148176,0.0012900315],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8173984,0.08364935,0.0042329016,0.00067176746,0.001597721,0.00021634588,0.00031745338,0.0017393457,0.030182786,0.0002213877,0.0028043336,0.05696812],"study_design_scores_gemma":[0.7273359,0.2615524,0.006529506,0.000023539766,0.00058094563,0.00011190627,0.00005828955,0.000606308,0.0015728635,0.00010160305,0.0015015336,0.000025321817],"about_ca_topic_score_codex":0.0021426007,"about_ca_topic_score_gemma":0.004760497,"teacher_disagreement_score":0.0037271741,"about_ca_system_score_codex":0.0011760023,"about_ca_system_score_gemma":0.002137962,"threshold_uncertainty_score":0.012468636},"labels":[],"label_agreement":null},{"id":"W3171042793","doi":"10.1016/j.ctarc.2021.100405","title":"Safety, pharmacokinetics, and efficacy of budigalimab with rovalpituzumab tesirine in patients with small cell lung cancer","year":2021,"lang":"en","type":"article","venue":"Cancer Treatment and Research Communications","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Cilag; Takeda Oncology; Chugai Pharmaceutical; Genentech; Aptitude Health; Sierra Oncology; Sociedad Española de Oncología Médica; PharmaMar; European Society for Medical Oncology; Oryzon Genomics; Astellas Pharma; Eisai; MacroGenics; Mersana Therapeutics; Agios Pharmaceuticals; BeiGene; Clovis Oncology; Loxo Oncology; Astex Pharmaceuticals; Les Laboratories Pierre Fabre; Pfizer; Incyte; Taiho Pharmaceutical; Regeneron Pharmaceuticals; Array BioPharma; Daiichi Sankyo Europe; Servier; Gilead Sciences; Glenmark Pharmaceuticals; AbbVie; Exelixis; Sanofi; Bristol-Myers Squibb; Ignyta; Eli Lilly and Company; EUSA Pharma; AstraZeneca; Argenx; American Society of Clinical Oncology; GlaxoSmithKline; Amgen; LAM Therapeutics; Celgene","keywords":"Tolerability; Medicine; Internal medicine; Adverse effect; Lung cancer; Oncology; Pharmacokinetics; Pleural effusion; Clinical trial; Gastroenterology","score_opus":0.06452351404831635,"score_gpt":0.41405822557187255,"score_spread":0.3495347115235562,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3171042793","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99737096,0.0014641223,0.0002609106,0.00007887121,0.000011239967,0.00008316561,0.00008364556,0.000026551732,0.0006204619],"genre_scores_gemma":[0.99927896,0.00014527832,0.0001799388,0.000062299216,0.000020889605,0.00003068837,0.00014050488,0.0000051779316,0.00013622656],"study_design_codex":"design_other","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9992449,0.00034724898,0.000037061975,0.00014329594,0.0001485642,0.00007897864],"domain_scores_gemma":[0.9989329,0.00028925674,0.0003701909,0.000076787335,0.00006336862,0.00026744505],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014900721,0.00032472148,0.0008650759,0.0002454212,0.0002634947,0.00075796724,0.00035239258,0.00048618007,0.00058808585],"category_scores_gemma":[0.002431808,0.00026554835,0.0005273123,0.00028089652,0.00043396006,0.0005671962,0.0002024975,0.0010992954,0.00031789375],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.26588613,0.007397161,0.26933724,0.00045674047,0.0013336913,0.0018631555,0.0008543678,0.009807106,0.16422631,0.00027852887,0.0023387175,0.27622083],"study_design_scores_gemma":[0.029614763,0.26276007,0.6445775,0.00008579104,0.0013669232,0.004467581,0.00029489,0.013971505,0.034710016,0.00028340344,0.0077943644,0.00007318535],"about_ca_topic_score_codex":0.0006131092,"about_ca_topic_score_gemma":0.0010415725,"teacher_disagreement_score":0.0014900721,"about_ca_system_score_codex":0.00080379867,"about_ca_system_score_gemma":0.0006718174,"threshold_uncertainty_score":0.00788033},"labels":[],"label_agreement":null},{"id":"W3211214132","doi":"10.1016/j.ctarc.2021.100484","title":"Integrating NGS-derived mutational profiling in the diagnosis of multiple lung adenocarcinomas","year":2021,"lang":"en","type":"article","venue":"Cancer Treatment and Research Communications","topic":"Lung Cancer Diagnosis and Treatment","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital; Université de Montréal; McGill University Health Centre","funders":"McGill University Health Centre","keywords":"KRAS; Adenocarcinoma; Lung cancer; DNA sequencing; Medicine; Mutation rate; Lung; Metastasis; Mutation; Cancer; Oncology; Computational biology; Internal medicine; Gene; Biology; Genetics; Colorectal cancer","score_opus":0.1571328090392377,"score_gpt":0.4517968917299002,"score_spread":0.29466408269066247,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3211214132","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9905894,0.0004004293,0.008573889,0.00003876496,0.0000043550103,0.000026490748,0.00008854477,0.000047185385,0.0002309607],"genre_scores_gemma":[0.9923664,0.000072202165,0.007365439,0.000012022612,0.0000049653668,0.00000882332,0.00012652288,0.000004036337,0.00003955319],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987404,0.00053480815,0.0001389547,0.0001898427,0.00031889448,0.000077209195],"domain_scores_gemma":[0.9974005,0.0015129951,0.00043910337,0.00020727685,0.00025400234,0.00018610414],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0026543757,0.00047472666,0.0005261981,0.0016228666,0.00021451271,0.000593153,0.0002798834,0.00034000658,0.00038850788],"category_scores_gemma":[0.006169298,0.00030223772,0.0003666191,0.00066603615,0.00028626068,0.00038750938,0.0007756242,0.0002903717,0.00011593305],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004188343,0.000034559398,0.96033424,0.00003429798,0.000082048326,0.0005413387,0.00005590009,0.0052620764,0.010354816,0.00003645163,0.000047267968,0.022798175],"study_design_scores_gemma":[0.000042492247,0.0008168905,0.7727305,0.0000451734,0.0003505718,0.007994085,0.00019873513,0.1945613,0.021859255,0.0007229619,0.0006417518,0.00003622129],"about_ca_topic_score_codex":0.001220035,"about_ca_topic_score_gemma":0.0031674798,"teacher_disagreement_score":0.0026543757,"about_ca_system_score_codex":0.00043350089,"about_ca_system_score_gemma":0.0004727095,"threshold_uncertainty_score":0.0140378475},"labels":[],"label_agreement":null},{"id":"W3214742056","doi":"10.1016/j.ctarc.2021.100496","title":"Consolidative durvalumab outcomes in stage III non-small cell lung cancer in a multi-centre study","year":2021,"lang":"en","type":"article","venue":"Cancer Treatment and Research Communications","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Ottawa; Ottawa Hospital; Queen's University","funders":"","keywords":"Durvalumab; Medicine; Pneumonitis; Internal medicine; Discontinuation; Lung cancer; Stage (stratigraphy); Clinical endpoint; Hazard ratio; Cancer; Oncology; Radiation therapy; Retrospective cohort study; Gastroenterology; Lung; Immunotherapy; Nivolumab; Clinical trial; Confidence interval","score_opus":0.13774220181707245,"score_gpt":0.464566545389948,"score_spread":0.3268243435728756,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3214742056","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9994547,0.00025481204,0.000044598644,0.000015933196,0.0000037805555,0.000018594106,0.000117732845,0.0000015544753,0.000088270295],"genre_scores_gemma":[0.99963117,0.00004808666,0.00004101401,0.000015803309,0.000008544317,0.000008823954,0.0002086653,8.6679063e-7,0.00003706647],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998835,0.0004009294,0.00009086102,0.0003657199,0.00017589076,0.00013164592],"domain_scores_gemma":[0.99734575,0.00025632096,0.0012941052,0.00026701041,0.00023948064,0.0005973013],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016426711,0.00039498977,0.0007011306,0.00032406833,0.0004286493,0.00094331766,0.00063113094,0.00039261588,0.0008465274],"category_scores_gemma":[0.0019602142,0.00029101747,0.00087807217,0.0005301961,0.00031950988,0.0005097878,0.0006610561,0.0004989504,0.00018076782],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005277996,0.0002576336,0.9889797,0.000052852065,0.00068926805,0.00020262026,0.00014637958,0.00010181432,0.00094468583,0.000021244537,0.00016262637,0.0031631277],"study_design_scores_gemma":[0.00051971944,0.002156423,0.995621,0.00001332962,0.00034202103,0.00039144658,0.00013934562,0.00029722668,0.0002029916,0.000016318761,0.00028817734,0.000011993038],"about_ca_topic_score_codex":0.0033774695,"about_ca_topic_score_gemma":0.0068370462,"teacher_disagreement_score":0.0033774695,"about_ca_system_score_codex":0.00094393484,"about_ca_system_score_gemma":0.0005512465,"threshold_uncertainty_score":0.008687377},"labels":[],"label_agreement":null},{"id":"W3214859407","doi":"10.1016/j.ctarc.2021.100494","title":"Aging-associated immune system changes in multiple myeloma: The dark side of the moon.","year":2021,"lang":"en","type":"review","venue":"Cancer Treatment and Research Communications","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; Ottawa Hospital","funders":"National Cancer Institute; National Institutes of Health","keywords":"Immunosenescence; Immunosurveillance; Immune system; Disease; Immunology; Medicine; Immunotherapy; Bone marrow; Senescence; Internal medicine","score_opus":0.24505326140434658,"score_gpt":0.465090804440809,"score_spread":0.22003754303646245,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3214859407","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00008460147,0.9987275,0.00005472856,0.0002872087,0.00022583768,0.000002462467,0.00001240773,0.00000536177,0.0005998416],"genre_scores_gemma":[0.00055927294,0.9982393,0.00010221709,0.0002753712,0.0002039879,0.0000033195806,0.000022640434,0.0000011924704,0.0005926813],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998555,0.000026752756,0.000018962623,0.000020779644,0.000062125306,0.000015822785],"domain_scores_gemma":[0.99974805,0.000096157186,0.000038734408,0.000007770314,0.00008366863,0.000025605443],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00040256293,0.00053704676,0.00083370804,0.0015472067,0.00024705616,0.0008500719,0.0005049692,0.0009602248,0.0028960593],"category_scores_gemma":[0.0006228333,0.00019296996,0.00045167064,0.0016642459,0.0003144302,0.0011149155,0.00052585494,0.0016106333,0.0015106925],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000086341344,0.00005424902,0.00022200054,0.019454455,0.00008323337,0.00015575168,0.00009425076,0.0002137515,0.0024524464,0.003257418,0.05201615,0.9219099],"study_design_scores_gemma":[0.000012423318,0.000121037294,0.0012809306,0.004470265,0.000093190625,0.0010993017,0.00006722858,0.00006610681,0.00038624668,0.001971634,0.99041826,0.0000134288775],"about_ca_topic_score_codex":0.001156981,"about_ca_topic_score_gemma":0.0022861974,"teacher_disagreement_score":0.0028960593,"about_ca_system_score_codex":0.0004839005,"about_ca_system_score_gemma":0.0010811405,"threshold_uncertainty_score":0.009688318},"labels":[],"label_agreement":null},{"id":"W3216326311","doi":"10.1016/j.ctarc.2021.100495","title":"Rural vs urban inequalities in stage at diagnosis for lung cancer","year":2021,"lang":"en","type":"article","venue":"Cancer Treatment and Research Communications","topic":"Global Cancer Incidence and Screening","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Libin Cardiovascular Institute of Alberta; University of Calgary; University of Saskatchewan","funders":"Saskatchewan Health Research Foundation","keywords":"Relative risk; Medicine; Lung cancer; Incidence (geometry); Relative survival; Stage (stratigraphy); Confidence interval; Cancer registry; Rural area; Cancer; Internal medicine; Demography; Cohort; Pathology","score_opus":0.36605763880834563,"score_gpt":0.526954167958974,"score_spread":0.16089652915062835,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3216326311","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9974406,0.0003683434,0.00010742476,0.00021370567,0.000006846901,0.000006718685,0.0008509608,0.0000027080393,0.0010027743],"genre_scores_gemma":[0.9994759,0.000078573365,0.00002527022,0.000030889583,0.0000042305674,0.000003035463,0.0002180933,7.7845624e-7,0.00016315968],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99949014,0.0001559435,0.000027036602,0.00011615657,0.000057447516,0.00015327551],"domain_scores_gemma":[0.99883395,0.00019817406,0.0005694845,0.000058168407,0.00012241003,0.00021780861],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00049684965,0.00017563318,0.0001628724,0.0005528482,0.0003529997,0.0005159857,0.0002837697,0.0002045896,0.0035294858],"category_scores_gemma":[0.0012592935,0.00013890845,0.00026831063,0.0010848653,0.0004693021,0.0002781948,0.0006411743,0.0003016217,0.00029598788],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004826801,0.000010904571,0.9978987,0.000015689247,0.00006696067,0.000048181413,0.0001201671,0.00011001092,0.00016521054,0.00010149499,0.00017600093,0.0012383844],"study_design_scores_gemma":[0.0000034789323,0.000015794532,0.9992409,0.000008320222,0.000013117188,0.00005917381,0.00029162003,0.00009444106,0.000021077994,0.000041534553,0.00020841521,0.0000021322826],"about_ca_topic_score_codex":0.16808704,"about_ca_topic_score_gemma":0.31214184,"teacher_disagreement_score":0.16808704,"about_ca_system_score_codex":0.000958106,"about_ca_system_score_gemma":0.001105036,"threshold_uncertainty_score":0.3342173},"labels":[],"label_agreement":null},{"id":"W4213132440","doi":"10.1016/j.ctarc.2022.100534","title":"Integrating comprehensive genomic sequencing of non-small cell lung cancer into a public healthcare system","year":2022,"lang":"en","type":"article","venue":"Cancer Treatment and Research Communications","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"William Osler Health System; Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"KRAS; Medicine; Reimbursement; Clinical trial; Lung cancer; Oncology; Internal medicine; Targeted therapy; Cancer; Bioinformatics; Health care; Biology; Colorectal cancer","score_opus":0.13422541032650281,"score_gpt":0.45275745784603594,"score_spread":0.3185320475195331,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4213132440","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8984954,0.002626017,0.016304951,0.034042638,0.00021072364,0.0019660569,0.013329949,0.0011345929,0.031889696],"genre_scores_gemma":[0.97642696,0.0007996897,0.014944737,0.0026921097,0.00012952193,0.00024690464,0.0037125293,0.00003264117,0.0010148503],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99636024,0.001514717,0.00014758624,0.00040299763,0.0010080014,0.00056633184],"domain_scores_gemma":[0.9922598,0.0020495239,0.0012490378,0.0004000672,0.0023102355,0.0017313528],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0048732944,0.00029697292,0.00019062622,0.00092461193,0.0005873,0.0015670925,0.0007545815,0.000507812,0.0030056546],"category_scores_gemma":[0.00947374,0.00016202495,0.0003142168,0.0012251781,0.00047673806,0.00084175717,0.0019323106,0.00057773065,0.0003251344],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006827375,0.0007444729,0.6081508,0.0006797688,0.0003135931,0.00051278254,0.0006814944,0.008720541,0.0064442465,0.0028314285,0.036060702,0.33417746],"study_design_scores_gemma":[0.0003115826,0.0012811304,0.9332311,0.00047457783,0.00029321047,0.00051819347,0.0015628834,0.018709904,0.0024258804,0.0024257414,0.03871088,0.000054909135],"about_ca_topic_score_codex":0.24753422,"about_ca_topic_score_gemma":0.35915822,"teacher_disagreement_score":0.24753422,"about_ca_system_score_codex":0.010447196,"about_ca_system_score_gemma":0.031003824,"threshold_uncertainty_score":0.49218678},"labels":[],"label_agreement":null},{"id":"W4225121752","doi":"10.1016/j.ctarc.2022.100570","title":"Clinicopathological features of pulmonary mucinous adenocarcinoma: A descriptive analysis","year":2022,"lang":"en","type":"article","venue":"Cancer Treatment and Research Communications","topic":"Lung Cancer Diagnosis and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Medicine; Adenocarcinoma; Stage (stratigraphy); Internal medicine; Radiation therapy; Gastroenterology; Chemotherapy; Oncology; Lung cancer; Cancer; Population","score_opus":0.17980047877639949,"score_gpt":0.4549861908577606,"score_spread":0.2751857120813611,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4225121752","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99731255,0.00073826354,0.00016054099,0.000030375088,0.0000044827016,0.000038810667,0.0011234508,0.0000067606975,0.0005847756],"genre_scores_gemma":[0.99842,0.0002927207,0.00019985056,0.000015865024,0.0000107874075,0.000027187723,0.0009459649,0.0000018340314,0.00008570549],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99967897,0.00004347443,0.00008337404,0.00006572016,0.00008540958,0.00004294102],"domain_scores_gemma":[0.9984353,0.0003342912,0.0007229792,0.000067125155,0.00024936785,0.00019093786],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006864605,0.00016025828,0.00026951975,0.0024997974,0.0002775365,0.00040907096,0.00024107643,0.0001706616,0.0012304462],"category_scores_gemma":[0.0014381442,0.0001482091,0.0002857971,0.0016368133,0.0002384769,0.0004322572,0.0004095618,0.00015430231,0.00027485637],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000047189984,0.000008895024,0.9976374,0.000015219064,0.000010975908,0.00040580612,0.000040926316,0.000022729342,0.00020701923,0.000008103106,0.00010157443,0.0014941564],"study_design_scores_gemma":[0.000004463852,0.000091746035,0.99327797,0.000012221143,0.000019223808,0.0054278625,0.00030763546,0.00011654443,0.00011630515,0.000015532783,0.0006062953,0.000004246896],"about_ca_topic_score_codex":0.0009674007,"about_ca_topic_score_gemma":0.0017891139,"teacher_disagreement_score":0.0024997974,"about_ca_system_score_codex":0.00031568512,"about_ca_system_score_gemma":0.00031167304,"threshold_uncertainty_score":0.004116237},"labels":[],"label_agreement":null},{"id":"W4225264047","doi":"10.1016/j.ctarc.2022.100557","title":"How well do European patients understand cancer-associated thrombosis? A patient survey","year":2022,"lang":"en","type":"review","venue":"Cancer Treatment and Research Communications","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Cancer Foundation; University of Alberta","funders":"","keywords":"Medicine; Cancer; Thrombosis; Psychological intervention; MEDLINE; Family medicine; Intensive care medicine; Nursing; Internal medicine","score_opus":0.414638465832463,"score_gpt":0.4783249374725145,"score_spread":0.06368647164005148,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4225264047","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0026415598,0.9946997,0.00006079143,0.0014927388,0.00009189348,0.000011453633,0.0001555827,0.0000029181356,0.0008432889],"genre_scores_gemma":[0.016052745,0.9821031,0.00010917422,0.0012982831,0.00007360859,0.0000266613,0.0001590663,0.0000011653498,0.00017624086],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9992249,0.00036241242,0.00014487133,0.000077377896,0.00014474675,0.000045755387],"domain_scores_gemma":[0.99834025,0.0010445043,0.00029673983,0.00001489918,0.0002506822,0.0000529806],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017820911,0.0002875641,0.0012393432,0.00096285454,0.00014729715,0.00072424335,0.00039019,0.00096957874,0.0016571291],"category_scores_gemma":[0.005780071,0.000143805,0.0007030241,0.0019144525,0.00017034101,0.0009868371,0.00033924633,0.0006681628,0.000263825],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002872073,0.000093077666,0.010204967,0.06693496,0.0011374311,0.00015576194,0.00085334596,0.0001595928,0.00020884599,0.0007748414,0.02120366,0.8979863],"study_design_scores_gemma":[0.00036751726,0.00086347945,0.1260325,0.18545933,0.0048422054,0.0039165984,0.0033967674,0.0003551719,0.0005377045,0.001348981,0.6727374,0.00014220866],"about_ca_topic_score_codex":0.004026624,"about_ca_topic_score_gemma":0.0057843886,"teacher_disagreement_score":0.004026624,"about_ca_system_score_codex":0.0005257772,"about_ca_system_score_gemma":0.00091922254,"threshold_uncertainty_score":0.009424686},"labels":[],"label_agreement":null},{"id":"W4281722752","doi":"10.1016/j.ctarc.2022.100585","title":"Treatment patterns and survival outcomes of early-onset colorectal cancer patients in Alberta, Canada: a population-based study","year":2022,"lang":"en","type":"article","venue":"Cancer Treatment and Research Communications","topic":"Colorectal Cancer Screening and Detection","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Calgary; University of British Columbia; Alberta Health Services","funders":"Canadian Institutes of Health Research","keywords":"Colorectal cancer; Medicine; Demography; Cancer; Oncology; Population; Internal medicine; Gerontology; Environmental health; Sociology","score_opus":0.07038987003829185,"score_gpt":0.3882815592961511,"score_spread":0.31789168925785927,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4281722752","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9918745,0.0008844607,0.00013096562,0.00034460024,0.00001384193,0.00004934022,0.0049163704,0.000013599691,0.001772313],"genre_scores_gemma":[0.99665725,0.00043229706,0.00016623002,0.00015283494,0.000010256054,0.000015833419,0.0021072484,0.000003880257,0.00045423614],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990257,0.00006587946,0.000061876926,0.00015927141,0.00036912638,0.00031811337],"domain_scores_gemma":[0.99812025,0.00009775367,0.0005137458,0.00007321005,0.0006562599,0.0005387852],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005756516,0.00036949152,0.00036337055,0.0013725426,0.0016559173,0.0010735677,0.001114675,0.0004709178,0.0014488637],"category_scores_gemma":[0.0015625219,0.00031407963,0.00049186975,0.004358689,0.0007329104,0.0003261692,0.0006969417,0.00064590963,0.00018023429],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004195293,0.000024528756,0.9979195,0.000014961403,0.00003456517,0.000052474687,0.00013121669,0.00007022565,0.00007088039,0.000029077077,0.00052035344,0.0010903078],"study_design_scores_gemma":[0.000011687328,0.00002407307,0.99858946,0.000023501092,0.000032646865,0.00007887461,0.00043334358,0.0002146991,0.00002716533,0.000021487864,0.00053596316,0.000007128823],"about_ca_topic_score_codex":0.9827711,"about_ca_topic_score_gemma":0.9890482,"teacher_disagreement_score":0.018694578,"about_ca_system_score_codex":0.018694578,"about_ca_system_score_gemma":0.021515965,"threshold_uncertainty_score":0.13563931},"labels":[],"label_agreement":null},{"id":"W4282596597","doi":"10.1016/j.ctarc.2022.100592","title":"Interaction between tumor microenvironment, autophagy, and epithelial-mesenchymal transition in tumor progression","year":2022,"lang":"en","type":"review","venue":"Cancer Treatment and Research Communications","topic":"Autophagy in Disease and Therapy","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Autophagy; Tumor microenvironment; Metastasis; Cancer research; Carcinogenesis; Epithelial–mesenchymal transition; Tumor progression; Biology; Mechanism (biology); Tumor cells; Apoptosis; Cancer","score_opus":0.19836602034884418,"score_gpt":0.4991227410702917,"score_spread":0.30075672072144755,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4282596597","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00012831701,0.9988187,0.000066573666,0.0001890121,0.000114851966,0.00000315477,0.0000146385555,0.000005560627,0.0006592306],"genre_scores_gemma":[0.0006256969,0.99881256,0.0000817039,0.00008919547,0.00007694588,0.00000385679,0.00001841799,6.507222e-7,0.00029093403],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998883,0.000018949866,0.000019162566,0.000017925278,0.000041783664,0.000013744273],"domain_scores_gemma":[0.9998385,0.00007018404,0.000025036106,0.0000041900626,0.000044634242,0.000017505861],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029783405,0.00053469616,0.0009899952,0.0021988458,0.0002821134,0.0008242378,0.0004946351,0.00075971585,0.0027435918],"category_scores_gemma":[0.00045524279,0.00017868874,0.0004774707,0.0019378628,0.00032878952,0.0009032987,0.0004964129,0.0011346715,0.0011182757],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009250211,0.00007654096,0.0003657654,0.030124323,0.00013919358,0.00030162427,0.00010202129,0.00041183233,0.0025021704,0.0046197474,0.03224336,0.9290209],"study_design_scores_gemma":[0.000017720175,0.000113341484,0.002122788,0.006619087,0.00019508958,0.0020424994,0.00010061936,0.00013647544,0.00064000546,0.0029676969,0.9850211,0.000023566352],"about_ca_topic_score_codex":0.00091532414,"about_ca_topic_score_gemma":0.0022316268,"teacher_disagreement_score":0.0027435918,"about_ca_system_score_codex":0.00059950986,"about_ca_system_score_gemma":0.0011816724,"threshold_uncertainty_score":0.009178281},"labels":[],"label_agreement":null},{"id":"W4292640845","doi":"10.1016/j.ctarc.2022.100625","title":"Exploring the prognostic impact of tumor sidedness in ovarian cancer: A population-based survival analysis of over 10,000 patients","year":2022,"lang":"en","type":"article","venue":"Cancer Treatment and Research Communications","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Medicine; Proportional hazards model; Internal medicine; Survival analysis; Ovarian cancer; Population; Log-rank test; Cohort; Cancer; Oncology; Gynecology; Gastroenterology; Surgery","score_opus":0.22223543453226452,"score_gpt":0.4443921806036002,"score_spread":0.22215674607133568,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4292640845","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9993911,0.00019797699,0.000103182116,0.000013038834,0.0000018694543,0.000002975222,0.00019930229,0.0000023174855,0.00008818601],"genre_scores_gemma":[0.99935704,0.00011179858,0.000058615627,0.000006544589,0.00000657725,0.000005165601,0.0004016802,0.0000013188603,0.000051267198],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999684,0.000081284874,0.000036899837,0.00010024342,0.00005136816,0.000046248828],"domain_scores_gemma":[0.9992519,0.0001747549,0.00026213637,0.00011208969,0.000069552676,0.00012951098],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007936085,0.00020932271,0.0003603232,0.0008921008,0.00033657782,0.00049927016,0.00021871722,0.00033583725,0.0007659927],"category_scores_gemma":[0.0013627154,0.0002182587,0.00059732684,0.0010395992,0.00029658558,0.00050187274,0.0006297907,0.0003963603,0.00015093165],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012997712,0.000008836894,0.9985045,0.000004996489,0.00005639984,0.0000493716,0.000029875446,0.000072451774,0.00014793346,0.000006475774,0.000027404794,0.00096175115],"study_design_scores_gemma":[0.000008635341,0.00014770919,0.99842167,0.0000033447252,0.00006683903,0.00039405815,0.00013551091,0.0005140666,0.00005405196,0.00003264717,0.00021628848,0.0000052292144],"about_ca_topic_score_codex":0.0018108436,"about_ca_topic_score_gemma":0.0019913751,"teacher_disagreement_score":0.0018108436,"about_ca_system_score_codex":0.00020887294,"about_ca_system_score_gemma":0.00022995529,"threshold_uncertainty_score":0.004197061},"labels":[],"label_agreement":null},{"id":"W4306682001","doi":"10.1016/j.ctarc.2022.100652","title":"The impact of frailty on health outcomes in older adults with lung cancer: A systematic review","year":2022,"lang":"en","type":"review","venue":"Cancer Treatment and Research Communications","topic":"Frailty in Older Adults","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Lung cancer; Hazard ratio; Quality of life (healthcare); Gerontology; Population; Discontinuation; Cancer; Internal medicine; Confidence interval","score_opus":0.21127210852302403,"score_gpt":0.5519309706629966,"score_spread":0.34065886213997254,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4306682001","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0015593084,0.9976235,0.000074003845,0.00016151444,0.000046506793,0.00013603682,0.00023902087,0.000005112809,0.00015494018],"genre_scores_gemma":[0.02998413,0.96860427,0.0003494723,0.00039083356,0.00006666165,0.00031248527,0.0002062646,0.0000038385533,0.0000820697],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9960186,0.0013090624,0.0014510256,0.00029707013,0.0007792013,0.0001450105],"domain_scores_gemma":[0.97861576,0.015591957,0.004074092,0.00023994576,0.0012450615,0.00023309253],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006205908,0.0011407716,0.006435867,0.0063917898,0.00049773435,0.0019784828,0.0013006415,0.001448932,0.0026070036],"category_scores_gemma":[0.030843714,0.00076095416,0.0065946714,0.006998272,0.0006889156,0.0018073536,0.0012839553,0.0009848019,0.00017368766],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000154186,0.000009352081,0.0017193083,0.96206915,0.011387362,0.00008404216,0.00015568307,0.00008799903,0.00009028032,0.00010212614,0.0008423004,0.02329816],"study_design_scores_gemma":[0.00021283618,0.00019940714,0.013512611,0.86636496,0.10779918,0.00046604284,0.00022677044,0.00014530233,0.00014220926,0.0002609278,0.010625792,0.00004394184],"about_ca_topic_score_codex":0.009667573,"about_ca_topic_score_gemma":0.02988464,"teacher_disagreement_score":0.009667573,"about_ca_system_score_codex":0.0026931444,"about_ca_system_score_gemma":0.006807793,"threshold_uncertainty_score":0.032820344},"labels":[],"label_agreement":null},{"id":"W4309731105","doi":"10.1016/j.ctarc.2022.100662","title":"A reduced dosing strategy can work for Alectinib in ALK rearranged non small cell lung cancer","year":2022,"lang":"en","type":"article","venue":"Cancer Treatment and Research Communications","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Alectinib; Dosing; Lung cancer; Medicine; Cancer; Crizotinib; Oncology; Intensive care medicine; Internal medicine","score_opus":0.14559758084820454,"score_gpt":0.47367715177419567,"score_spread":0.32807957092599116,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4309731105","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6496345,0.046166644,0.07806639,0.093274444,0.009069956,0.002341059,0.003886891,0.005369898,0.11219027],"genre_scores_gemma":[0.9315333,0.0066641513,0.026193595,0.0120309135,0.0014216062,0.00042050157,0.0014295902,0.0002600131,0.020046428],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9996258,0.00008763521,0.000042154516,0.000067578665,0.00011698694,0.00005980878],"domain_scores_gemma":[0.99958926,0.00011265821,0.00008554644,0.00006936105,0.000079106285,0.00006408764],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006155763,0.00033849134,0.0006020049,0.00037107436,0.00031328833,0.001178475,0.0005868252,0.0007723667,0.0072874213],"category_scores_gemma":[0.0018259196,0.0001243722,0.00086263125,0.00023317186,0.00024711175,0.000828548,0.00030938015,0.0015640522,0.0019840363],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0044230176,0.0021681935,0.0054214788,0.00047891494,0.0005067937,0.00033549752,0.000075026604,0.004854016,0.054491736,0.00333878,0.032753795,0.89115274],"study_design_scores_gemma":[0.010301594,0.026517766,0.07488425,0.0011214009,0.0032373385,0.005003653,0.00041306624,0.028668694,0.13903525,0.025756624,0.68472016,0.00034020699],"about_ca_topic_score_codex":0.0009961596,"about_ca_topic_score_gemma":0.0024176408,"teacher_disagreement_score":0.0072874213,"about_ca_system_score_codex":0.0006881003,"about_ca_system_score_gemma":0.0007914233,"threshold_uncertainty_score":0.024378836},"labels":[],"label_agreement":null},{"id":"W4313368242","doi":"10.1016/j.ctarc.2022.100678","title":"A study of the efficacy and toxicity outcomes of extended durvalumab dosing in patients with stage III unresectable non-small cell lung cancer (NSCLC) during the COVID-19 pandemic","year":2022,"lang":"en","type":"article","venue":"Cancer Treatment and Research Communications","topic":"Lung Cancer Diagnosis and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Kingston Health Sciences Centre; Princess Margaret Cancer Centre; Queen's University; Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Dosing; Medicine; Durvalumab; Discontinuation; Toxicity; Lung cancer; Internal medicine; Adverse effect; Retrospective cohort study; Stage (stratigraphy); Cancer; Surgery; Oncology; Immunotherapy; Nivolumab","score_opus":0.08383939205344686,"score_gpt":0.41299750268721486,"score_spread":0.329158110633768,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4313368242","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9994123,0.0002308077,0.00003072424,0.000013073514,0.000002153622,0.000030464478,0.00007280724,0.0000010022477,0.00020675543],"genre_scores_gemma":[0.9995079,0.000097335585,0.000058117133,0.00003071326,0.0000123345235,0.00002313833,0.00020241064,6.0530306e-7,0.000067314395],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99945563,0.00019979876,0.000057806985,0.00009316482,0.00012826655,0.000065358],"domain_scores_gemma":[0.9978263,0.0005801894,0.0009590616,0.000128275,0.0001687068,0.00033742216],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017746498,0.00020569259,0.00041101995,0.00023642622,0.00018520419,0.00038148498,0.00023456574,0.00023401264,0.0005971552],"category_scores_gemma":[0.002226427,0.00010290607,0.0004893172,0.00034985208,0.00028772783,0.00033859513,0.00024614294,0.00039534824,0.00008520428],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.05577846,0.0023568126,0.8939437,0.00016404579,0.00078427256,0.00023449249,0.00030955562,0.0005306524,0.0029791314,0.00007099068,0.0003034937,0.042544328],"study_design_scores_gemma":[0.0024779858,0.060562722,0.93372387,0.000023809738,0.0003114761,0.00038950928,0.0001130627,0.0006774049,0.0006574208,0.000030581756,0.0010203563,0.000011698006],"about_ca_topic_score_codex":0.0016016747,"about_ca_topic_score_gemma":0.0020102446,"teacher_disagreement_score":0.0017746498,"about_ca_system_score_codex":0.0010455846,"about_ca_system_score_gemma":0.0005812687,"threshold_uncertainty_score":0.009385407},"labels":[],"label_agreement":null},{"id":"W4317470309","doi":"10.1016/j.ctarc.2023.100683","title":"Real-world treatment outcomes in HR+ HER2- metastatic breast cancer patients treated with CDK4/6 inhibitors: Results from a reference center in Brazil","year":2023,"lang":"en","type":"article","venue":"Cancer Treatment and Research Communications","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Medicine; Discontinuation; Internal medicine; Tolerability; Palbociclib; Neutropenia; Adverse effect; Breast cancer; Metastatic breast cancer; Gastroenterology; Oncology; Febrile neutropenia; Population; Cancer; Chemotherapy","score_opus":0.12236005037989336,"score_gpt":0.4448572747629137,"score_spread":0.3224972243830203,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4317470309","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9941551,0.001498631,0.00023560961,0.00019020021,0.0000069483426,0.000047510348,0.0026098615,0.000009712898,0.001246433],"genre_scores_gemma":[0.9970885,0.00072859303,0.00014888145,0.00007433214,0.000007927476,0.000028152503,0.0018331069,0.0000068352933,0.000083661595],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992342,0.00022106567,0.00012156496,0.00016089053,0.00014796494,0.00011428796],"domain_scores_gemma":[0.9971367,0.00052855577,0.0014155735,0.00017956144,0.00049801514,0.00024147153],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000988961,0.00022469943,0.00046725097,0.0009923876,0.0002613415,0.0007101017,0.00033106393,0.0002843566,0.0008299628],"category_scores_gemma":[0.00375798,0.00017061067,0.00060253753,0.0015321457,0.0003625505,0.0002932115,0.00056653784,0.00026270628,0.0001633505],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024677868,0.000067541754,0.9866899,0.00015453756,0.00013624398,0.00022426722,0.0006227138,0.00021718595,0.00035745572,0.0000982292,0.00058933365,0.010595897],"study_design_scores_gemma":[0.00007059094,0.00022631275,0.9956857,0.00010296243,0.00011993389,0.0005412155,0.0007461978,0.00032413355,0.00021396518,0.00004259735,0.0019133585,0.000012994728],"about_ca_topic_score_codex":0.03759288,"about_ca_topic_score_gemma":0.040773846,"teacher_disagreement_score":0.03759288,"about_ca_system_score_codex":0.0017733789,"about_ca_system_score_gemma":0.001519601,"threshold_uncertainty_score":0.07474816},"labels":[],"label_agreement":null},{"id":"W4327703589","doi":"10.1016/j.ctarc.2023.100696","title":"Next-generation sequencing of non-small cell lung cancer at a Quebec health care cancer centre","year":2023,"lang":"en","type":"article","venue":"Cancer Treatment and Research Communications","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill Genome Centre; McGill University; McGill University Health Centre","funders":"","keywords":"KRAS; Lung cancer; Medicine; Cancer; Oncology; Internal medicine; Cohort; Clinical trial; Targeted therapy; Bioinformatics; Biology; Colorectal cancer","score_opus":0.1813665434080559,"score_gpt":0.46875777750188424,"score_spread":0.28739123409382833,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4327703589","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9280482,0.0043356963,0.004309385,0.004790803,0.00010504795,0.0005733386,0.036768287,0.0002118545,0.02085734],"genre_scores_gemma":[0.9782745,0.0010650665,0.0037866198,0.0018218855,0.000034600755,0.00013834692,0.008677808,0.000047233672,0.0061538685],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995098,0.00007913787,0.000025729332,0.000114731905,0.00014736617,0.00012319763],"domain_scores_gemma":[0.9978132,0.00034753507,0.00016775914,0.000060969727,0.0012175946,0.00039302578],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007096271,0.00022577705,0.00021800312,0.00076953165,0.0013670998,0.00086094206,0.00045688872,0.0003765284,0.0056555844],"category_scores_gemma":[0.002204103,0.00011787939,0.00021087684,0.0012137081,0.00024237008,0.00018181086,0.00034165167,0.00038482327,0.00050222734],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00053834525,0.00013244795,0.8318252,0.00034619836,0.00016490961,0.0030262724,0.0017937416,0.0020307756,0.012163743,0.00096683286,0.048186507,0.09882499],"study_design_scores_gemma":[0.00006750431,0.00018184584,0.9411673,0.00030434373,0.00009566012,0.001072265,0.0019923453,0.004872433,0.0027059612,0.00021562974,0.047288932,0.000035833633],"about_ca_topic_score_codex":0.92257124,"about_ca_topic_score_gemma":0.9525152,"teacher_disagreement_score":0.07742876,"about_ca_system_score_codex":0.011711517,"about_ca_system_score_gemma":0.014101099,"threshold_uncertainty_score":0.15576947},"labels":[],"label_agreement":null},{"id":"W4384945340","doi":"10.1016/j.ctarc.2023.100746","title":"High tumor mutation burden (TMB) in microsatellite stable (MSS) colorectal cancers: Diverse molecular associations point to variable pathophysiology","year":2023,"lang":"en","type":"article","venue":"Cancer Treatment and Research Communications","topic":"Genetic factors in colorectal cancer","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"NOSM University; Essar Steel Algoma (Canada); Sault Area Hospital","funders":"","keywords":"KRAS; Microsatellite instability; Colorectal cancer; DNA mismatch repair; Cancer research; Mutation; Medicine; Epigenetics; Cancer; Biology; Gene; Internal medicine; Genetics; Microsatellite; Allele","score_opus":0.06664542607681266,"score_gpt":0.392304617592637,"score_spread":0.32565919151582434,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4384945340","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9973922,0.0017153895,0.00022086847,0.000046659214,0.0000017450319,0.0000044629423,0.00023401671,0.000009840282,0.00037472803],"genre_scores_gemma":[0.99925846,0.0003412944,0.00012969328,0.000009185353,0.0000056822455,0.0000029417374,0.00020820055,0.0000026387474,0.000041763753],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99971575,0.00005546496,0.000046591933,0.0000780536,0.00006469328,0.00003942481],"domain_scores_gemma":[0.99863106,0.0002908803,0.0007578705,0.00007968471,0.000094096904,0.00014647753],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00049320544,0.00019801251,0.0002867234,0.0021317534,0.00024055569,0.00047615854,0.00023760222,0.00034406423,0.0017227911],"category_scores_gemma":[0.001379109,0.0001303188,0.00018411959,0.0014555362,0.0003902674,0.00032929677,0.0005411211,0.00021469052,0.0002067049],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00038759192,0.000014262082,0.9817732,0.00007352439,0.00008549508,0.0005042868,0.000083828265,0.00008528963,0.011645353,0.000071584866,0.000072884206,0.005202653],"study_design_scores_gemma":[0.000004932784,0.0000810589,0.99477553,0.000013659213,0.00005811068,0.002996661,0.00013004692,0.000118596436,0.0014287933,0.00014124997,0.00024752013,0.0000038381254],"about_ca_topic_score_codex":0.0004862487,"about_ca_topic_score_gemma":0.0005691349,"teacher_disagreement_score":0.0021317534,"about_ca_system_score_codex":0.00018711232,"about_ca_system_score_gemma":0.00014651312,"threshold_uncertainty_score":0.0057632923},"labels":[],"label_agreement":null},{"id":"W4385285672","doi":"10.1016/j.ctarc.2023.100747","title":"Survival outcomes and predicting intracranial metastasis in stage III non-small cell lung cancer treated with definitive chemoradiation: Real-world data from a tertiary cancer center","year":2023,"lang":"en","type":"article","venue":"Cancer Treatment and Research Communications","topic":"Brain Metastases and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Juravinski Cancer Centre; Hamilton Health Sciences; Kingston Health Sciences Centre; Ottawa Hospital; Queen's University","funders":"","keywords":"Medicine; Lung cancer; Center (category theory); Oncology; Stage (stratigraphy); Internal medicine; Tertiary care; Brain metastasis; Distant metastasis; Metastasis; Real world data; Cancer; Biology; Computer science; Chemistry","score_opus":0.17347780638350102,"score_gpt":0.4341727992050757,"score_spread":0.26069499282157466,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4385285672","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99891067,0.00009676575,0.000055745073,0.00003389119,0.0000019457832,0.000007137805,0.00073544384,0.0000032568832,0.00015514481],"genre_scores_gemma":[0.9988368,0.000053112504,0.00006262254,0.000015080436,0.000004907494,0.0000064975798,0.0009851684,0.0000015242833,0.000034324108],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9994518,0.00014157992,0.00009022802,0.00012862975,0.00010887086,0.00007885003],"domain_scores_gemma":[0.9974197,0.0003982083,0.0014579057,0.00018538321,0.00022880486,0.0003100694],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007178433,0.00019435765,0.00026686766,0.00068086735,0.00029952923,0.00052561617,0.00042956867,0.00031586664,0.0010089043],"category_scores_gemma":[0.0023718353,0.00017505135,0.00036091384,0.0011073621,0.0002665732,0.00031174024,0.00055979413,0.0003392245,0.00024974847],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006097406,0.000015617044,0.99883515,0.000007658117,0.000022122904,0.000054371576,0.000050432835,0.00008402647,0.00006733801,0.0000046251553,0.00013385584,0.00066383724],"study_design_scores_gemma":[0.0000086817345,0.00005346787,0.99904495,0.00000574586,0.000017279446,0.00018812975,0.0001572931,0.0003122505,0.000058361242,0.0000074565305,0.00014266915,0.0000036415615],"about_ca_topic_score_codex":0.011194497,"about_ca_topic_score_gemma":0.015418984,"teacher_disagreement_score":0.011194497,"about_ca_system_score_codex":0.00084543234,"about_ca_system_score_gemma":0.0006318035,"threshold_uncertainty_score":0.022258699},"labels":[],"label_agreement":null},{"id":"W4387491491","doi":"10.1016/j.ctarc.2023.100767","title":"The prognostic impact of KRAS, TP53, STK11 and KEAP1 mutations and their influence on the NLR in NSCLC patients treated with immunotherapy","year":2023,"lang":"en","type":"article","venue":"Cancer Treatment and Research Communications","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"Université de Montréal","keywords":"STK11; KRAS; Immunotherapy; Oncology; Medicine; Internal medicine; Cancer","score_opus":0.07313046330335114,"score_gpt":0.40848728692078057,"score_spread":0.3353568236174294,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387491491","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9990916,0.0005380496,0.000041271207,0.00002165867,0.0000027252738,0.000002651198,0.00006207523,0.0000010636124,0.0002387755],"genre_scores_gemma":[0.9996668,0.00010175602,0.000032998312,0.000010211721,0.00000670301,0.00000240471,0.00011294504,8.8887845e-7,0.00006535454],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99968934,0.00008292394,0.00004403763,0.000055075976,0.0000653086,0.000063265536],"domain_scores_gemma":[0.99911517,0.00030455296,0.00034994687,0.000048389295,0.000057229638,0.00012460859],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000565932,0.00011853802,0.00032657993,0.00042795055,0.00024705663,0.00048783456,0.00016666073,0.00028738377,0.0006860799],"category_scores_gemma":[0.0013443052,0.00013586626,0.00045485393,0.0004796304,0.0002455642,0.00038653976,0.00021926261,0.00033781337,0.00014941067],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00094602135,0.000018266524,0.99486536,0.00000913143,0.00004145906,0.00016300615,0.000024209716,0.00009954849,0.0006574861,0.000009747025,0.000033094388,0.0031327445],"study_design_scores_gemma":[0.000015209768,0.0003779276,0.9975673,0.0000058786477,0.000065431785,0.00086839404,0.000070312424,0.00039770588,0.00033592168,0.000031650005,0.00025977954,0.000004528734],"about_ca_topic_score_codex":0.0006086186,"about_ca_topic_score_gemma":0.001314165,"teacher_disagreement_score":0.0006860799,"about_ca_system_score_codex":0.0004080157,"about_ca_system_score_gemma":0.00025938146,"threshold_uncertainty_score":0.0029929876},"labels":[],"label_agreement":null},{"id":"W4388343130","doi":"10.1016/j.ctarc.2023.100774","title":"Presentation and outcomes of KRASG12C mutant non-small cell lung cancer patients with stage IV disease at diagnosis (de novo) versus at recurrence","year":2023,"lang":"en","type":"article","venue":"Cancer Treatment and Research Communications","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Juravinski Cancer Centre; Princess Margaret Cancer Centre; McMaster University; Dalhousie University; University of Toronto; University Health Network","funders":"Amgen Canada","keywords":"Medicine; Hazard ratio; Internal medicine; Stage (stratigraphy); Oncology; Targeted therapy; Progressive disease; Lung cancer; Cancer; Disease; Gastroenterology; Confidence interval","score_opus":0.0782646992820013,"score_gpt":0.4428730312875759,"score_spread":0.3646083320055746,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388343130","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9994678,0.00011874654,0.000014246113,0.000017878123,0.0000032667992,0.0000037207783,0.00014131767,0.0000010624949,0.00023202],"genre_scores_gemma":[0.99959177,0.00004451238,0.000009047189,0.0000109207085,0.0000066551124,0.0000033978608,0.00026154146,7.3448086e-7,0.00007139182],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997403,0.00004235573,0.000033257693,0.00006794385,0.00003069841,0.00008538078],"domain_scores_gemma":[0.998901,0.0001718499,0.0004688011,0.000035374225,0.0000776843,0.00034531543],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027615053,0.00024711905,0.0004107254,0.0006499769,0.00034921514,0.0005598126,0.00026369674,0.00054275116,0.00156539],"category_scores_gemma":[0.0015558292,0.0001590227,0.00049209205,0.000589898,0.0002742266,0.00055095257,0.0005553328,0.00050064834,0.00025934313],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000304562,0.000031873977,0.99802315,0.0000071929294,0.000031375144,0.00029423463,0.00006370793,0.00006357471,0.00026016482,0.000015625095,0.000067763656,0.00083680183],"study_design_scores_gemma":[0.000016430931,0.00037859264,0.9978528,0.0000065996655,0.00002704606,0.0010994766,0.00024286086,0.00016806892,0.00006644805,0.000035727982,0.00009859997,0.0000072748517],"about_ca_topic_score_codex":0.0025717313,"about_ca_topic_score_gemma":0.002840868,"teacher_disagreement_score":0.0025717313,"about_ca_system_score_codex":0.00053422264,"about_ca_system_score_gemma":0.00023905648,"threshold_uncertainty_score":0.005236745},"labels":[],"label_agreement":null},{"id":"W4402933007","doi":"10.1016/j.ctarc.2024.100846","title":"Low to intermediate grade lung neuroendocrine tumours. A single centre real world experience","year":2024,"lang":"en","type":"article","venue":"Cancer Treatment and Research Communications","topic":"Neuroendocrine Tumor Research Advances","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Neuroendocrine tumour; Lung; Medicine; Pathology; Internal medicine","score_opus":0.10716445222904525,"score_gpt":0.4641708018772585,"score_spread":0.35700634964821326,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402933007","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99830425,0.0004987757,0.0001360458,0.000060990773,0.0000066751954,0.000026044205,0.00012858723,0.000006566844,0.0008320355],"genre_scores_gemma":[0.9992448,0.00025052202,0.00010748758,0.00004746658,0.000010837716,0.0000088477145,0.00016612587,0.0000025523148,0.00016142077],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996506,0.000054457392,0.00003781107,0.00007402858,0.000088772475,0.00009441052],"domain_scores_gemma":[0.99903333,0.00016455083,0.00029766856,0.000053928907,0.00009547434,0.00035513405],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030693584,0.00031339767,0.00022586361,0.0004426417,0.00069557014,0.00071980385,0.00038368662,0.00039523857,0.0022445333],"category_scores_gemma":[0.0015012266,0.00020993913,0.00019507094,0.00068179105,0.00044695445,0.00032684248,0.00057507027,0.00034032032,0.0005503978],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002009232,0.00019662477,0.974649,0.00007900056,0.000022859143,0.013707209,0.0008513954,0.00010621809,0.0007328304,0.000049964063,0.00043667672,0.008967368],"study_design_scores_gemma":[0.000114151444,0.0012382328,0.90560573,0.00008193301,0.00005137888,0.085981,0.002604366,0.00038276846,0.00068194314,0.00008263581,0.003137163,0.000038763286],"about_ca_topic_score_codex":0.01199611,"about_ca_topic_score_gemma":0.016949663,"teacher_disagreement_score":0.01199611,"about_ca_system_score_codex":0.00096009445,"about_ca_system_score_gemma":0.0009966575,"threshold_uncertainty_score":0.023852587},"labels":[],"label_agreement":null},{"id":"W4408348828","doi":"10.1016/j.ctarc.2025.100896","title":"Real-world evaluation of treatment patterns and clinical outcomes in patients with BRAF-V600E metastatic colorectal cancer (mCRC) in Canada","year":2025,"lang":"en","type":"article","venue":"Cancer Treatment and Research Communications","topic":"Colorectal Cancer Treatments and Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Canadian Electricity Association; Ottawa Hospital; University of Ottawa","funders":"Pfizer Canada","keywords":"Colorectal cancer; Medicine; Oncology; Internal medicine; Cancer","score_opus":0.15642130535958787,"score_gpt":0.4939102658841411,"score_spread":0.33748896052455324,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408348828","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.995233,0.00024086669,0.0000578907,0.00016358304,0.0000034625937,0.000024888011,0.0033056582,0.000005445238,0.00096519565],"genre_scores_gemma":[0.9984706,0.00010907488,0.00007782505,0.000030592273,0.0000024864694,0.00000798038,0.0011619345,0.0000017330398,0.00013766768],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99916685,0.00009467384,0.00008510108,0.00016302992,0.0002567628,0.00023364654],"domain_scores_gemma":[0.9970892,0.0001927729,0.0011390031,0.000072914714,0.0009847009,0.0005214546],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005319179,0.00015632989,0.00024371874,0.0010022708,0.0011062551,0.0008040851,0.00063365424,0.0003119406,0.0012779325],"category_scores_gemma":[0.0027614094,0.00014505188,0.00029027983,0.0026670243,0.00050403917,0.0002908333,0.00062396727,0.00034777404,0.00016900884],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004252669,0.0000075057706,0.9985759,0.000008676524,0.000012494291,0.000032630982,0.00008145025,0.000054876928,0.00004340075,0.000011780486,0.00017809619,0.0009506805],"study_design_scores_gemma":[0.0000031777017,0.000026251719,0.998823,0.0000072367725,0.000009025001,0.00009627843,0.00044357358,0.00019438208,0.000039563758,0.000008172544,0.00034488304,0.0000045343268],"about_ca_topic_score_codex":0.8587384,"about_ca_topic_score_gemma":0.9057098,"teacher_disagreement_score":0.14126158,"about_ca_system_score_codex":0.010914233,"about_ca_system_score_gemma":0.0076397914,"threshold_uncertainty_score":0.28418696},"labels":[],"label_agreement":null},{"id":"W4413439314","doi":"10.1016/j.ctarc.2025.100982","title":"Impact of adjuvant therapy on survival in treatment of CNS hemangiopericytomas","year":2025,"lang":"en","type":"article","venue":"Cancer Treatment and Research Communications","topic":"Soft tissue tumor case studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Research Institute in Oncology and Hematology; CancerCare Manitoba","funders":"","keywords":"Hemangiopericytoma; Adjuvant therapy; Medicine; Adjuvant; Oncology; Internal medicine; Chemotherapy; Radiology","score_opus":0.244250553721533,"score_gpt":0.5373752427245475,"score_spread":0.29312468900301447,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413439314","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9923423,0.0062104985,0.0002886246,0.00013270979,0.000020782676,0.00001120471,0.00006165588,0.000007380704,0.0009248168],"genre_scores_gemma":[0.9983998,0.0011026452,0.0001891611,0.00003696965,0.000018830495,0.000010536009,0.00011482701,0.0000013552515,0.00012596627],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99991333,0.00003015909,0.000012380169,0.00000893272,0.000014953201,0.000020316133],"domain_scores_gemma":[0.99958676,0.000161357,0.00013335697,0.000013130492,0.000035405974,0.00007005524],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029903476,0.000101030084,0.00017634584,0.00013452274,0.00010290931,0.00013917919,0.00009923076,0.00009806882,0.000584461],"category_scores_gemma":[0.00092859624,0.000022902266,0.00016423335,0.000109006316,0.000080698395,0.00012700197,0.00013478685,0.00021408097,0.000046625417],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010213125,0.0011747429,0.5015563,0.00043773302,0.00024159013,0.001722144,0.00019691834,0.003219577,0.010313905,0.00020767504,0.0010572561,0.4696591],"study_design_scores_gemma":[0.0005180069,0.017628217,0.9570194,0.00036125246,0.00068430864,0.0064011943,0.00020050333,0.0036221405,0.0067596645,0.00046818564,0.00632192,0.0000152161565],"about_ca_topic_score_codex":0.00038666083,"about_ca_topic_score_gemma":0.0008615625,"teacher_disagreement_score":0.000584461,"about_ca_system_score_codex":0.0002226298,"about_ca_system_score_gemma":0.00029357374,"threshold_uncertainty_score":0.0019552112},"labels":[],"label_agreement":null},{"id":"W4415306169","doi":"10.1016/j.ctarc.2025.101021","title":"Retrospective database analysis to assess treatment patterns, clinical outcomes, and healthcare resource utilization in metastatic or recurrent HER2-positive breast cancer in Alberta","year":2025,"lang":"en","type":"article","venue":"Cancer Treatment and Research Communications","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"AstraZeneca (Canada); Alberta Cancer Foundation; University of Calgary; Foothills Medical Centre","funders":"AstraZeneca","keywords":"Metastatic breast cancer; Breast cancer; Recurrent breast cancer; Health care; Medical diagnosis; Retrospective cohort study; Cancer treatment","score_opus":0.37454311074845226,"score_gpt":0.5960753306706257,"score_spread":0.22153221992217342,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415306169","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9626164,0.0013456692,0.00039853086,0.00017873311,0.000014534718,0.00026096817,0.032895833,0.00003439457,0.002254892],"genre_scores_gemma":[0.9806333,0.0006313243,0.0006286736,0.00013863291,0.000011601581,0.00012833266,0.017367018,0.000008480859,0.00045261753],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99796677,0.0002120412,0.00023771574,0.00034469832,0.0007866495,0.00045226264],"domain_scores_gemma":[0.99494725,0.0004533366,0.0016085458,0.00037633316,0.0020454987,0.0005690257],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016843644,0.00043365135,0.0005650814,0.0040598135,0.0014503483,0.001290018,0.001615949,0.00040211843,0.0014308977],"category_scores_gemma":[0.004384834,0.00043268673,0.000726046,0.011968365,0.00043833716,0.00028576658,0.0008848298,0.0004585224,0.00020942473],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000091651746,0.000020392486,0.99699235,0.000042596137,0.000096098585,0.000062913576,0.00009602694,0.00015128481,0.00005899006,0.000051729883,0.00086941454,0.001466586],"study_design_scores_gemma":[0.000019661153,0.000028931598,0.9975327,0.000039115675,0.00007908059,0.00013000552,0.00041828986,0.000558803,0.000051694875,0.000018927954,0.0011144927,0.000008187854],"about_ca_topic_score_codex":0.9723188,"about_ca_topic_score_gemma":0.9720625,"teacher_disagreement_score":0.027681172,"about_ca_system_score_codex":0.021349067,"about_ca_system_score_gemma":0.023970935,"threshold_uncertainty_score":0.15489906},"labels":[],"label_agreement":null},{"id":"W4416426290","doi":"10.1016/j.ctarc.2025.101040","title":"Artificial intelligence in Glioblastoma Diagnostics: Integrating MRI, histopathology, and molecular profiling","year":2025,"lang":"en","type":"article","venue":"Cancer Treatment and Research Communications","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"National Institute for Genetic Engineering and Biotechnology","keywords":"Workflow; Profiling (computer programming); Glioblastoma; Precision medicine; Applications of artificial intelligence; Molecular diagnostics","score_opus":0.08045639848709268,"score_gpt":0.43916104033496267,"score_spread":0.35870464184787,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416426290","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0011231214,0.9868363,0.0017745349,0.00723976,0.0003972651,0.00027817622,0.00043633327,0.000021460939,0.0018930231],"genre_scores_gemma":[0.046360623,0.9308465,0.014936534,0.005149508,0.0008404024,0.0011045691,0.00039232892,0.00003181279,0.0003377439],"study_design_codex":"systematic_review","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.95328754,0.029669402,0.011058792,0.0013522689,0.0043443395,0.00028763432],"domain_scores_gemma":[0.7610769,0.21754134,0.011340697,0.002380152,0.0071262037,0.0005347643],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.045575242,0.0010322807,0.0030308205,0.011566858,0.00053074904,0.0057042814,0.001375145,0.0020181946,0.0031185006],"category_scores_gemma":[0.14160182,0.00069959986,0.0039834087,0.0065778242,0.0023961165,0.0037942503,0.002083629,0.002256128,0.0003726265],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00045329754,0.00003307714,0.0016535063,0.59097904,0.0052368143,0.000107438056,0.0007506944,0.0009985022,0.00024426472,0.0082752425,0.008035796,0.38323224],"study_design_scores_gemma":[0.00024260268,0.00040400514,0.0051161465,0.85532635,0.011806846,0.0003847344,0.0010144684,0.0007991536,0.0007180194,0.020532092,0.10354781,0.000107816515],"about_ca_topic_score_codex":0.005474428,"about_ca_topic_score_gemma":0.00886214,"teacher_disagreement_score":0.045575242,"about_ca_system_score_codex":0.004999546,"about_ca_system_score_gemma":0.010340252,"threshold_uncertainty_score":0.24102783},"labels":[],"label_agreement":null}]}